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 Abstract 
Identification and Characterization of the IMC Protein Family in Toxoplasma 
gondii  
Brooke R. Anderson-White 
Thesis advisor: Dr. Marc-Jan Gubbels 
The apicomplexan parasite Toxoplasma gondii divides rapidly and asexually through a 
unique process of internal daughter budding. The physical infrastructure for this process 
is the cytoskeleton, which is composed of subpellicular microtubules, flattened vesicles 
(alveoli), and a meshwork of intermediate filament-like proteins. This meshwork is 
composed of a family of 14 inner membrane complex (IMC) proteins that were identified 
based on the presence of a repeat sequence shared across the Alveolata, the alveolin-
repeat. All 14 proteins were cloned as YFP fusions to study their subcellular localization 
and antibodies were generated against several representative IMC proteins. Each IMC 
displays unique spatio-temporal dynamics throughout development, but four physically 
distinct localizations were identified: eight IMCs localize to the alveoli, four IMCs 
localize to a structure known as the basal complex, IMC11 localizes to the apical cap in 
mature parasites, and IMC15 localizes primarily to the centrosomes and early buds. 
IMC15 is of particular interest because its appearance before membrane occupation and 
recognition nexus 1 (MORN1) in the early bud suggests that it is the first cytoskeletal 
component to associate with the buds. A conditional knockdown of this protein using the 
destabilization domain (DD) reveals IMC15 has a strong affinity for the centrosomes that 
overcomes targeting of the DD fusion protein to the proteasome and the presence of 
 IMC15 in the early bud may not be necessary for the division process. Conditional 
knockdowns using a tetracycline repressible promoter reveal that a minimal amount of 
IMC15 is sufficient for parasite survival. In order to further characterize IMC15, 
dominant negative constructs based on mutating putative palmitoylation sites or 
overexpression of deletion constructs are being pursued. Collectively, the IMC family is 
being incorporated into the temporal and spatial dynamics of cytoskeletal development 
through the creation of a comprehensive timeline of daughter bud assembly. These 
findings are contributing unprecedented detail to the cell division process.  
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Chapter 1. Cytoskeletal development in Toxoplasma gondii 
 2 
 
1.1. Introduction 
Toxoplasma gondii is the obligate intracellular apicomplexan parasite responsible for 
toxoplasmosis-associated encephalitis and birth defects (1). Other medically significant 
members of the Apicomplexa phylum include the causative agent of malaria 
[Plasmodium species (spp.)] (2), opportunistic infections that cause acute gastroenteritis 
(Cryptosporidium spp.) (3), and several costly veterinary scourges (Eimeria, Theileria, 
and Babesia spp.) (4-6). The virulence of these parasites and the destruction perpetrated 
by these organisms is correlated to their rapid rate of replication with duplication 
occurring about every six hours (7-9). This rapid rate of cell division in Toxoplasma is 
predicated on proper formation of the cytoskeleton (10-16).  
 
1.2. Division by internal daughter budding 
The fast replicating Toxoplasma tachyzoite divides asexually by a process of internal 
daughter budding known as endodyogeny (17-20) (Fig. 1.1). The process begins with the 
duplication of the Golgi late in G1 (17, 21-23). This is followed by the duplication of the 
centrosome early in S phase (19, 24, 25) (Fig. 1.1B). Budding is initiated in S-phase as 
well when the early components of the cytoskeleton begin to assemble apically to the 
centrosomes (9, 13, 17, 19, 26-29) (Fig.1.1C and D). Mitosis and cytokinesis progress 
concurrently as the cytoskeleton grows from the apical end toward the posterior end 
encapsulating first the divided Golgi (25), then the apicoplast (30), (Fig. 1.1E), the 
nucleus (19) and endoplasmic reticulum (ER) (31) (Fig. 1.1 F), and finally the 
mitochondrion (25) (Fig. 1.1G and A). The secretory organelles are created de novo 
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during this process (17, 22, 25) (Fig. 1.1 G). As the daughter parasites reach maturity, the 
cytoskeleton of the mother breaks down and the plasma membrane of the mother is 
recycled on to the now emerging daughters (17) (Fig. 1.1F and G). The cell cycle takes 
only six hours to complete and is continuous until host cell lysis (9).  
 
1.3. Composition of the cytoskeleton 
1.3.1. Ultrastructure 
The Toxoplasma cytoskeleton is composed of two parts: the inner subpellicular 
microtubules (MT) and the outer pellicle. There are 22 subpellicular MT that spiral two-
thirds of the length of the parasite (Fig. 1.2F). The minus ends of the MT are anchored in 
the microtubule organizing center (MTOC) called the apical polar ring (Fig. 1.2E). The 
MT grow from the apical end of the parasite toward the posterior end, with the (+)ends 
remaining free in the mature parasite (32, 33). Unlike other eukaryotes, single MT in 
apicomplexans are extremely stable (34). Some of this stability could be attributed to the 
microtubule-associated proteins (MAPs) that are suspected to connect the MT to the 
pellicle (34, 35). This MT stability is necessary as Toxoplasma lacks an actin 
cytoskeleton. The majority of actin remains in the globular form in Toxoplasma (36), 
transiently forming filaments to act during gliding and host cell invasion as part of the 
motility apparatus known as the glideosome (37, 38). Inhibition of or interference with 
actin significantly decreases motility and invasion (38, 39). However, actin is not 
necessary for proper internal budding and only affects the turnover of the mother’s 
organelles, leading to a larger than normal residual body (40). Furthermore, conventional 
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myosin is absent from the Toxoplasma cytoskeleton and only divergent Type XIV 
myosins (41-43) are found in the glideosome (44-46). As with actin, interruption of 
myosin reduces motility (47). Disruption of the MT on the other hand halts daughter 
budding supporting its essential cytoskeletal role (16, 40, 48).  
 The pellicle is comprised of an outer plasma membrane (Fig. 1.2A), the alveoli of 
the inner membrane complex (IMC) (Fig. 1.2 yellow), and the IMC protein mesh (Fig. 
1.2 bright green), which lines the cytoplasmic side of the alveoli and overlays the 
subpellicular MT (17, 28, 49). The alveoli are ER-Golgi derived flattened membranous 
sacs that form the double membrane of the IMC (17, 50). They are arranged in three rows 
encircling the parasite with a single capping vesicle at the apical end (49, 51). These 
alveoli are the defining feature of the Alveolata, a superphylum consisting of ciliates, 
dinoflagellates, and apicomplexans. The IMC protein mesh is composed of 8-10 nm wide 
intermediate filament-like (IF-like) proteins (28). The combination of alveoli and 
intermediate filaments are believed to serve primarily as structural supports or armor in 
most alveolates, but in the Apicomplexa they also serve as support for the glideosome 
(28, 44). Within the double membranes of the alveoli there are double rows and single 
rows of intramembranous particles (IMPs) organized with a 32 nm periodicity, reflecting 
the periodicity of the subpellicular MT (34, 49, 51). It has been hypothesized that the 
double rows of IMPs anchor the MAPs that interact with the MT to further stabilize the 
cytoskeleton (34, 35); but the single rows of IMPs run the entire length of the parasite 
suggesting they may interact with the IMC IF-like proteins (28). Disruption of the MT 
with the dinitroaniline herbicide oryzalin does not affect the development and 
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organization of the IMPs, supporting the hypothesis that they interact with alternative 
filaments like the IMC IF-like proteins (34).  
The IMC runs the entire length of the parasite with openings at the apical and 
posterior ends. The opening at the apical end allows for the extension of the conoid that is 
necessary for host cell invasion (32, 52-55). The conoid consists of two preconoidal rings 
at the most anterior end of the parasite (Fig. 1.2C) and the apical polar ring that organizes 
the subpellicular MT (Fig. 1.2E). These rings are connected by spiraling α-tubulin-only 
MT (17, 32, 35, 56-58) (Fig. 1.2D).  In addition there are two short intraconoid MT that 
may serve to transport secretory proteins during invasion (32, 59) (Fig. 1.2B). The 
opening at the posterior end is occupied by a structure known as the posterior cup or 
basal complex (28) (Fig. 1.2G). The function of the basal complex in the mature parasite 
is unknown.   
 
1.3.2. Sub-compartments and protein families of the mature cytoskeleton 
Studies of the cell biology of Toxoplasma reveal a more compartmentalized cytoskeleton 
than described in Section 1.3.1 and a growing complexity in the number of protein 
components. At the most apical end of the parasite, appearing to localize to the anterior 
preconoidal ring, there is the EF-hand containing calcium binding protein TgCentrin2 
(Fig. 1.3B). This protein is believed to drive constriction of the basal complex during 
division (60). Posterior to TgCentrin2 is ring-1 (RNG1), which localizes to the apical 
polar ring. (Fig. 1.3B). The function of RNG1 is unknown but it does assemble in the 
absence of MT and may be essential (15). Faintly expressed near the conoid is the 
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membrane occupation and recognition nexus 1 (MORN1) protein (60, 61) (Fig. 1.3B). 
Knockouts (KO) of MORN1 show it plays an essential role in the organization of the 
basal complex and is necessary for proper constriction during cytokinesis (10, 11). 
TgCentrin3, a homolog of TgCentrin2, is found faintly in the conoid as well along with 
two additional EF-hand, calcium-binding domain proteins, TgCAM1 and TgCAM2 
(Fig.1.3B). The latter two proteins may play a role in conoid extrusion in response to 
calcium (27). The (-)end-directed MT motor dynein light chain (TgDLC) localizes to the 
apical end of the parasite and may transport cargo along the MT (Fig. 1.3B). It may be 
involved in calcium signaling as well (27). Another MT-associated protein, the 
intraconoid microtubule associated protein 1 (TgICMAP1), interacts exclusively with the 
two intraconoid MT and probably fulfills a stabilizing function (62) (Fig. 1.3C).  
 TgDLC also appears less intensely in a structure below the conoid region called 
the apical cap (27), which could correspond to the first alveolin vesicle (Fig. 1.3A). 
Photosensitized INA-labeled protein 1 (PhIL1) localizes to this region as well (63) (Fig. 
1.3A). Though the function of PhIL1 is currently unknown, KO of PhIL1 results in 
shorter, wider parasites that are outcompeted by wild-type parasites in tissue culture and 
are less infective to mice (64). A component of the glideosome, gliding-associated 
protein 70 (GAP70), also localizes to the apical cap (Fig. 1.3A). This protein is closely 
related to GAP45, which recruits the members of the glideosome to the IMC (44, 65), and 
it appears to function similarly to GAP45 by recruiting the glideosome components to the 
apical end of the parasite. Loss of GAP70 by KO does not result in a growth defect by 
plaque assay suggesting that GAP45 may be compensatory (65).  
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In addition a member of the IMC sub-compartment protein (ISP) family, ISP1, 
localizes to the apical cap (Fig. 1.3A). The ISP family is a group of three highly charged, 
apicomplexan-specific, IMC-associated proteins that share a strongly conserved C-
terminal region. These proteins are soluble, unlike other cytoskeletal elements, and are 
anchored to the IMC by palmitoylation (14, 28). Knockout of ISP1 leads to no obvious 
defects in morphology or growth. In the absence of ISP1, ISP2 and ISP3 appear to 
compensate for the loss. It seems ISP1 acts as a gatekeeper to limit the access of other 
proteins to the apical cap but the reason for this is unknown (14).  
The edge of the apical cap is decorated with five to six annuli of TgCentrin2 (Fig. 
1.3A). These TgCentrin2 accumulations could be at the sutures between the alveolin cap 
and the first row of five to six alveoli. It appears these annuli arise from an early cloud of 
TgCentrin2 that forms around the centrosome early in budding and may function in IMC 
organization. Furthermore, these annuli may bind MT because disruption of MT with 
oryzalin leads to their random dispersion throughout the cell (27).  
 ISP2 occupies a region of the cytoskeleton that runs from the apical cap to about 
two-thirds the length of the parasite (Fig. 1.3A). This central compartment is not bounded 
by the ends of the subpellicular MT but instead appears to follow the edges of a row of 
IMC alveoli. A KO strain of ISP2 suffers outcompetition by wild-type parasites in tissue 
culture. When ISP2 is not present, about 40% of parasites experience the formation of 
multiple buds that are incapable of successful development (14). Currently ISP2 is the 
only identified protein within this mid-parasite compartment.  
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 The final member of the ISP family coincides with the boundaries of the IMC 
with an apical gap for the conoid and a posterior gap for the basal complex. ISP3 is 
associated with the IMC but not a part of the protein meshwork (Fig. 1.3A). Knockout 
does not result in any gross defects, thus the function of ISP3 remains unclear (14). In 
addition to ISP3, GAP50, an integral membrane protein of the outer layer of the IMC 
alveoli, localizes to the entire IMC (44) (Fig. 1.3A). GAP50 anchors the glideosome to 
the IMC through GAP45, which is necessary for proper motility (65). The remaining 
glideosome elements, myosin light chain 1 (MLC1) and myosin A (MyoA), are 
associated with GAP45 (44, 66). GAP40 was identified recently as a new glideosome 
component potentially associated with the IMC (65) (Fig. 1.3A). Those proteins that do 
localize to the IMC meshwork are IMC1 (19, 28, 67), 3 (68), and 4 (27) (Fig. 1.3A).  
 At the posterior end of the cytoskeleton is the basal complex (28). MORN1 and 
TgCentrin2 appear in this structure, which could reinforce prominent roles for these 
components in constriction of the parasite during cytokinesis (27, 60, 61) (Fig. 1.3A). 
TgDLC localizes to the basal end as well; however its expression is quite faint (27) (Fig. 
1.3A). 
 
1.4. Mechanistic insights from gene and protein disruptions 
As evidenced in the preceding sections, the subcellular dynamics of some components of 
the Toxoplasma cytoskeleton have been described, but little has been done to elucidate 
the mechanisms of development. Targeted gene KOs, protein destabilizers, dominant 
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negative constructs, and destructive overexpression have been applied to begin teasing 
out the potential functions of certain cytoskeletal elements. 
 Initial research into the mechanisms of daughter budding focused on the 
subpellicular MT. When parasites are treated with a high dose of oryzalin the 
subpellicular MT fail to form (16, 48). The early IMC will begin to assemble but the 
cytoskeleton’s ability to elongate and accomplish cytokinesis is blocked (40, 48). 
Centrosome duplication is not affected by MT disruption (40). ISP1 and MORN1 will 
form several rings in parasites treated with oryzalin and ISP3 will collect at these early 
structures (14, 60, 61). GAP50 association with the early IMC continues as well (46). 
IMC1 will continue to accumulate at these early buds but will form sheets without MT 
(27). The appearance of RNG-1 in treated cells supports proper formation of the conoid, 
or at least the apical polar ring, without MT. It is somewhat unusual that the number of 
centrosomes and RNG-1 rings do not agree in affected parasites but the signal still 
remains to trigger late-stage RNG-1 formation without the MT or nuclear division (15). 
These data suggest MT are not involved in initiation of budding or in early bud formation 
but are necessary for proper IMC elongation and completion of cytokinesis. It is possible 
the unaffected centrosome may play a significant role in these early stages. 
 Rab11B is a small GTPase that traffics the alveoli of the IMC. Experiments 
inducing a dominant negative phenotype of Rab11B show that a lack of alveoli 
biogenesis halts bud formation. IMC1, MORN1, and GAP50 all fail to appear. Despite 
the ablation of IMC formation, the subpellicular MT still polymerize but are not properly 
shaped (13). In ISP2 KO parasites the MT develop as well, but again they do not appear 
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to be properly shaped. In these parasites, nascent IMCs, as indicated by ISP1, do not 
coincide with the MT structures and appear as amorphous, random accumulations (14). 
Therefore, IMC formation is not required for MT polymerization but is required for 
proper bud morphology.  
 Nuclear division and functional cytoskeletal development do not appear to be 
linked. KO of ISP2, which affects the earliest stages of daughter budding, still presents 
properly divided nuclei in the majority of affected cells (14). The dominant negative 
Rab11B phenotype that completely inhibits IMC formation does not affect nuclear 
division (13). Even when contraction of the daughter buds malfunctions in the MORN1 
KO parasites, nuclear division is unaffected (10). Nuclear division is clearly not linked to 
IMC formation and it is questionable if it is linked to subpellicular MT formation. When 
parasites are treated with a high dose of oryzalin the nucleus fails to divide properly but 
this is most likely due to interference with the spindle MT (16, 48). When the 
concentration of oryzalin is kept low (0.5 µM), the spindle forms and the nucleus divides, 
but the cytoskeleton is not fully functional and the daughter parasites can no longer 
invade host cells (48).  
 Aside from addressing big questions like if IMC and subpellicular MT 
development are tightly linked and if nuclear division and cytoskeletal development are 
mutually exclusive, very little information on the detailed interactions of the cytoskeleton 
have come out of gene and protein disruptions to date. GAP70, PhIL1 and ISP1 KOs 
illustrate that there probably exists a high rate of redundancy or compensatory pathways 
in cytoskeletal development (14, 64, 65). Disruption of ISP2 leads to a gross defect in 
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budding, but not in all parasites, and its interactions with other cytoskeletal proteins are 
unknown (14). The MORN1 KO provides a clear role for the protein in completion of 
cytokinesis as all parasites are affected by its loss, but why or how formation and 
constriction of the basal complex fails is unknown (10). 
 
1.5. Open questions on the Toxoplasma cytoskeleton 
The process of internal daughter budding and specifically cytoskeletal development 
remains poorly defined. As the pathogenesis of Toxoplasma is closely linked to its rapid 
rate of replication and replication hinges on proper formation of its cytoskeleton this is an 
aspect of parasite biology that demands increased attention. Furthermore, this structure 
provides an optimal target for improved therapeutic treatments as it is largely constructed 
of proteins not found in the mammalian host cell. 
In order to better define cytoskeletal development it is necessary to identify and 
characterize the proteins of the cytoskeleton. The sequenced genome of Toxoplasma 
eases the identification of protein families and the robust cell biological tools make their 
characterization possible. Once the spatial and temporal behavior of the protein is 
defined, deeper characterization of its functionality should follow. Gene KOs will be a 
useful tool in this pursuit. Post-translational modifications merit a close look as well since 
they play a prominent role in the mechanisms of protein targeting and organization (10, 
14, 65). Finally, this information can be used to develop models of cytoskeletal 
development in Toxoplasma.  
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This work is focused on the identification and characterization of a family of IMC 
intermediate filament-like proteins. Included as well is a deeper analysis of IMC15, the 
member of this family believed to play a role in cytoskeletal nucleation. Furthermore, the 
timing of IMC15 and the rest of the IMC family has been put in perspective by 
establishing a molecular level timeline of early budding events.  
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Figure 1.1. Toxoplasma divides by internal daughter budding 
(A) Mature parasite in G1. Red are MT (conoid, subpellicular, and spindle pole), yellow 
are the alveoli, bright green is the IMC meshwork, brown are secretory vesicles, dark 
blue line is the mitochondrion, purple is the apicoplast, blue is the centrosome, black is 
the Golgi, dark green is the ER, grey is the nucleus, and pink is the posterior cup or basal 
complex. (B) Mitosis is initiated at 1.2N with the duplication of the centrosomes 
following the duplication of the Golgi. (C) Budding is initiated with the appearance of 
early components of the cytoskeleton. (D) The spindle pole duplicates and the apicoplast 
moves below the centrosomes, elongating as the centrosomes separate. (E) The 
organelles begin to partition as the daughter buds elongate. The components of the basal 
complex accumulate at the leading edge of the bud. (F) The daughter buds contract and 
all the organelles are partitioned except for the mitochondrion. The secretory vesicles and 
cytoskeleton of the mother begin to degrade. (G) Daughter buds emerge and the plasma 
membrane from the mother is incorporated onto the daughters. The mother falls away as 
a residual body. 
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Figure 1.1. Toxoplasma divides by internal daughter budding 
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Figure 1.2. The cytoskeleton is a two part, trimembrane structure 
Diagram of the layers of the cytoskeleton. The pellicle is on the left and right. The MT 
are in the middle. On the left is the exterior of the alveoli in yellow after removal of the 
plasma membrane (A) shown in grey. On the right are the IMC IF-like proteins in bright 
green after removal of the alveoli. The cross-sectioned bi-membranes of the alveolin 
vesicles are in yellow. (B-E) The conoid of the parasite is composed of two intraconoidal 
MT (B), two preconoidal rings (C), spiraling α-tubulin-only MT (D), and the apical polar 
ring (E). (F) The 22 spiraling subpellicular MT are the innermost layer of the 
cytoskeleton. (G) The posterior cup or basal complex is at the end of the IMC. 
 
 16 
Figure 1.2. The cytoskeleton is a two part, trimembrane structure 
 
 
 17 
Figure 1.3. Cytoskeletal sub-compartments of Toxoplasma 
(A) Sub-compartments are the apical cap (blue curved lines), mid-parasite region (green 
stripes), IMC (bright green), and posterior cup consisting of MORN1 (pink), TgDLC 
(blue), and TgCentrin2 (red). TgCentrin2 annuli and preconoidal localization in red as 
well. Names of proteins occupying each region are in corresponding colors. (B and C) 
Exterior and interior enlargements of the conoid, respectively.  
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Figure 1.3. Cytoskeletal sub-compartments of Toxoplasma 
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Chapter 2. A family of intermediate filament-like proteins is sequentially 
assembled into the cytoskeleton 
 20 
2.1. Introduction 
A rapid replication cycle and the resultant tissue lesions are responsible for the 
pathogenesis of Toxoplasma. Since the ability to replicate is intrinsically linked to the 
proper development of the cytoskeleton (10-16), the components of this structure are 
attractive potential therapeutic targets and comprise a growing area of research. The 
meshwork of 8-10 nm intermediate filament-like proteins that lines the alveoli of the 
IMC and overlies the MTs is particularly appealing as the IMC serves to support the 
actin-myosin motor apparatus that is required for host cell invasion (28, 44). 
Furthermore, in apicomplexans, the developing IMC functions as a scaffold for 
organellogenesis and organelle partitioning during division (69). Finally, the critical roles 
of two protein components of this meshwork in Plasmodium berghei, IMC1a and IMC1b, 
in cell stability and division were directly demonstrated through genetic knock-outs (70, 
71). 
In Toxoplasma, the first component of this meshwork, IMC1, was identified using 
polyclonal antibodies raised against extracted cytoskeletons (28). The second component, 
IMC3, arose from the use of a genomic YFP-fusion library (68). A third component, 
IMC4, was identified in purifications of the apical complex (27). All three localize to the 
cortical IMC; however, initial findings with IMC1 and IMC3 showed their dynamics to 
be  slightly different (68, 72). As presented in Figure 2.1, IMC3 expresses strongly in the 
budding daughters, but its intensity decreases as the daughters mature and progress 
through G1, and the IMC1 signal remains constant throughout the cell cycle.  
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The common motif that joins these dynamically different IMC proteins together 
as a family emerged when Gould et al. analyzed genome sequence data for all the 
Alveolata (ciliates, dinoflagellates, and apicomplexans) (73) and defined a family of 
proteins related to IMC1, 3 and 4, which all carry a series of conserved repeats called 
alveolin repeats (74). The alveolin repeat motif contains conserved valine- and proline-
rich domains composed of “EKIVEVP” and “EVVR” or “VPV” subrepeats (74). As the 
first three IMC proteins were identified in different labs and through different screening 
techniques there is a high probability the IMC meshwork contains more proteins that 
carry this repeat motif. The importance of the IMC to the parasite and the possibility that 
the individual IMC proteins may behave differently led us to hypothesize that these 
proteins could fulfill different functions within various stages of the parasite’s life cycle 
including cytoskeletal assembly, maturation, maintenance, and disassembly. 
In this chapter, 14 alveolin domain containing genes are identified in the T. gondii 
sequenced genome database. Subsequently we studied the subcellular localizations of 
each using YFP-tagged constructs and specific antisera. We identified a number of 
unique spatio-temporal patterns in addition to those previously described, such as a group 
of IMC proteins exclusively localizing to the basal complex, an IMC protein colocalizing 
with the centrosomes, and a group of IMC proteins exclusively localizing to the mature 
cytoskeleton. Taken together, a surprising level of diversity in the localization patterns 
and potential functions of the alveolin-repeat IMC proteins outlines the developmental 
stages of the Toxoplasma tachyzoite cell division at an unprecedented spatio-temporal 
resolution. 
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2.2. Results 
2.2.1. Genome mining to identify the IMC family 
Since the identification of IMC1, 3, and 4 was not as part of a comprehensive search for 
IMC proteins, we identified additional IMC genes through querying the fully sequenced 
T. gondii genome in ToxoDB using IMC1, 3, and 4 as seeds (75). This approach 
identified a total of 14 related IMC genes containing an alveolin domain (Table 2.1). We 
validated the splicing of IMC genes 7, 9, and 12-15 by RACE PCR and DNA sequencing. 
Only IMC14 and IMC15 varied from the predicted gene models: IMC14 has several 
splice variants in the Prugniaud strain, but only one in the RH strain (the RH sequence 
was used in this study), and IMC15 has different start and stop codons (Fig. 2.2). The 
remaining IMC genes have consistent gene prediction models and we were able to 
amplify their open reading frames from tachyzoite cDNA to confirm these annotations. 
The alveolin domain regions were determined using the REPRO program, which 
identifies repetitive sequences within a single sequence, and potential palmitoylation sites 
were predicted with CSS-Palm 2.0 (Fig. 2.3) (76, 77). 
 
2.2.2. Coordinated IMC gene expression 
Coordinated gene expression patterns among proteins with related functions have been 
observed during the erythrocytic development of the apicomplexan Plasmodium 
falciparum (78, 79). To see if this applies to the IMC proteins, the expression patterns 
were assembled for each of the identified IMC genes from genome-wide microarray 
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expression data (80). The majority of the IMC genes (IMC1, 3-6, 8-11, 13, and 15) 
display a highly coordinated expression profile reaching a maximum coinciding with 
budding, whereas IMC7 and 12 exhibit a profile opposing the majority and IMC14 trails 
the majority pattern by 1 hour (Fig. 2.4A). When comparing the absolute mRNA 
expression levels, only IMC9 and 15 stand out with maximum expression levels less than 
the minimum levels of almost all the other IMC genes (Fig. 2.4B). Furthermore, many 
mRNAs displayed up to a 10-fold dynamic range between minimum and maximum 
suggesting that although timing of expression is coordinated for most IMC genes, their 
expression levels are quite variable.  
 
2.2.3. Comparisons of cortical IMC proteins in budding and mature parasites 
Although IMC proteins 1, 3, and 4 had been characterized previously, it was never 
formally established how these three proteins localize relative to one another. When 
IMC1 and IMC3 are compared it is clear that more IMC3 is associated with the budding 
daughter cytoskeletons than with the cytoskeleton of the mother cell, as opposed to the 
more equal distribution that IMC1 exhibits (Fig. 2.5B, C, and D). The high intensity of 
IMC3 is maintained in the recently emerged daughters but then drops to lower basal 
levels in fully mature daughters (Fig. 2.1 and Fig. 2.5B, C, and D). Comparable results 
were obtained with parasites expressing YFP-tagged versions of IMC1 and IMC3 
indicating that the observed differences were not due to masking of the antibody binding 
site (Fig. 2.5E and F). When IMC4 is compared to IMC1 and IMC3 using a parasite line 
expressing YFP-IMC4, it is found to localize like IMC1 with equal distribution in the 
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mother and daughter buds (Fig. 2.6A and B). This pattern is corroborated with a C-
terminal fusion, IMC4-YFP, as well (Fig. 2.6C).  
To assess the subcellular localizations of the novel IMC proteins we generated N-
terminal YFP fusions for each protein and expressed them in T. gondii. The expressed 
fusion proteins were verified through western blot (Fig. 2.7). Live parasites were imaged 
to identify the subcellular distribution patterns of the fusion proteins and, in addition, 
their localization dynamics were determined in all cases relative to IMC3 with an IMC3 
antibody. Among the novel IMC proteins we identified two, IMC6 and IMC10, which 
show a localization pattern like IMC3 (Fig. 2.8A-D and F-I). This pattern is the same 
with C-terminal YFP fusions (Fig. 2.8E and J). Taken together IMC3, 6, and 10 comprise 
a related group of cortical IMC proteins distinct from IMC1 and 4 based on their 
behavior during parasite development. 
 
2.2.4. IMC7, 12, and 14 localize exclusively to the mature cytoskeleton 
In contrast to the IMC proteins described above, IMC7, 12, and 14 are excluded 
from the budding daughters and only found in the mature cortical IMC (Fig. 2.9B, E, G, 
L, O, and Q). The cortical localization of IMC7, 12, and 14 does not correspond with the 
emergence of mature daughters (Fig. 2.9C, H, and P) but instead occurs sometime before 
the initiation of budding (Fig. 2.9A and N). C-terminal fusions of IMC7 and 12 confirm 
these observed patterns (Fig. 2.9F and M) and this behavior is not unexpected based on 
the delays in the expression profiles of IMC7, 12, and 14 (Fig. 2.4A). To verify that 
expression of YFP-IMC7, 12, and 14 do not interfere with maturation we used a 
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glideosome component, GAP45, which is incorporated into the IMC upon daughter 
maturation (12). As shown in Figure 2.9, GAP45 did associate with the cortex of the 
emerging daughters expressing cytoplasmically localized YFP-IMC7, 12, and 14, while 
some of the respective IMC protein is still in the cortex of the disassembling mother (D, 
I, and R). It is important to note that IMC7 and 14 are expressed under their native 
promoters instead of the α-tubulin (ptub) promoter as ptub closely matches the 
expression patterns of the majority of the IMC proteins but not these (Fig. 2.4A) (80). 
The IMC12 expression pattern is the same under the ptub promoter and its native 
promoter, but under the native promoter it fades rapidly during imaging; therefore, ptub 
driven YFP-IMC12 is presented here (Fig. 2.9J and K).  
 To determine the timing of the shift of IMC7 and 12 to the cortical IMC, time-
lapse movies of YFP-IMC7 and YFP-IMC12 parasite lines were collected throughout 
tachyzoite development (Fig. 2.10A). The movies show that the time between the end of 
cytokinesis and the reappearance of the cortical YFP localization is approximately two 
hours. Thus the transition of these IMC proteins occurs in G1 (9). Collection of a 
comparable IMC14 movie failed due to the rapid bleaching of the weak YFP signal.  
 To more accurately describe the timing of this transition we employed a 
temperature sensitive mutant, FV-P6, which grows normally at 35°C and then arrests 
near the midpoint of G1 when cultured at 40°C (24, 25, 81). When N-terminal cherryRFP 
fusions of IMC7 and IMC14 are expressed in this mutant and scored for cortical vs. 
cytoplasmic localization at 35°C in an asynchronous parasite population, both proteins 
are fairly evenly distributed between the two locations (Fig. 2.10B through E). When the 
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parasites are grown at 40°C either after 18 hrs at 35°C or immediately upon inoculation, 
IMC7 remains evenly distributed but IMC14 becomes nearly 100% cortical (Fig. 2.10D 
and E). This suggests that IMC14 transitions to the cortical IMC early in G1 and IMC7 
transitions later, more towards the midpoint of G1. These findings are further supported 
by the expression data in Figure 2.4A. 
 
2.2.5. IMC11 localizes to the apical cap 
Expression of a YFP tagged IMC11 driven by either the ptub or its endogenous promoter, 
resulted in localization of IMC11 to the buds, weak expression of YFP in an area of the 
cortex known as the apical cap, and an even weaker localization to the basal end of the 
IMC (Fig. 2.11A and B). The localization to the apical cap was confirmed through co-
expression of a cherryRFP tagged version of PhIL1, an IMC-associated protein of 
unknown function (63) (Fig. 2.11C). The number of parasites that could be captured with 
visible basal IMC11 signal was too low to make a firm observation regarding basal 
colocalization. Using a MORN1 antibody, which highlights the basal complex (82), the 
basal localization of YFP-IMC11 is supported (Fig. 2.11D), but the poor YFP signal 
again did not permit a firm colocalization assignment. Antiserum was raised against full-
length IMC11 because IMC11 is too small to use only the non-alveolin domains. This 
unfortunately made it cross-reactive with the alveolin motifs in other IMC proteins 
preventing the confirmation of the YFP fusion. 
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2.2.6. Four IMCs are components of the basal complex 
At the basal end of the parasite, within the posterior IMC gap, is a structure called the 
basal complex or posterior cup that extracts with the cytoskeleton (28). The composition 
of this structure is largely unknown with only three previously suggested components: 
MORN1, TgCentrin2, and TgDLC, that all localize to the apical and basal extremes of 
the mature parasite (27, 60, 61). As presented in Figure 2.11, IMC11 is another potential 
component of this structure that localizes to both extremes as well. Unlike these 
previously described basal complex members, we identified four proteins that localize 
exclusively to the basal end of the mature parasite: IMC5, 8, 9, and 13 (Fig. 2.12). This 
group expresses in the whole daughter bud in the first half of budding and then halfway 
through budding they shift toward the basal complex (Fig. 2.12A). IMC8 is provided as 
an example as all members of this group behave in the same manner. Additionally, 
tagging on the N- and C-termini result in the same localization patterns as demonstrated 
by IMC13-YFP (Fig. 2.12B). A specific antiserum against the N-terminus of IMC5 
further confirms the dynamics observed with the YFP fusions (Fig. 2.12C) and the 
localization of IMC5 to the basal complex when co-stained with anti-IMC1 and anti-
MORN1 (Fig. 2.12D and E).  
 With several components of the posterior end now identified we performed co-
IFAs with these proteins to document subtle differences in their localization patterns that 
could lead to greater insight into the structure of the basal complex (Fig. 2.12F). These 
colocalization studies resulted in the documentation of a three tiered structure in the basal 
complex: the upper and outermost tier contains MORN1, IMC9, 13, and 15; the middle 
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tier is composed of IMC5 and 8; and the most basal and innermost tier contains 
TgCentrin2, which partially overlaps with the IMC5 and 8 structure. IMC15 will be 
discussed in Section 0. Because definitive validation of these spatial relationships is 
limited by the resolution of light microscopy we sought to test whether the colocalizing 
proteins were interacting with each other and/or with their neighbors by yeast two-hybrid 
analysis. Unfortunately, these results were largely inconclusive (Table 2.2).  
Since these distinctive basal structures have not been described at the 
ultrastructural level, in collaboration with Dr. David Ferguson, University of Oxford, UK, 
we performed electron microscopy (EM) on the basal complex (Fig. 2.12G-J). Two 
distinct electron-dense structures were observed in the basal complex: one directly 
attached to the cytoplasmic side of the basal end of the IMC (the basal inner ring or BIR; 
Fig. 2.12J) and a second structure separated from the IMC and the inner ring, but 
extending over the same length of the basal IMC and bending toward the plasma 
membrane (the basal inner collar or BIC) (Fig. 2.12H-J). Though it is difficult to obtain a 
large number of properly sectioned parasites, among 30 parasites with properly oriented 
basal complexes the majority displayed this folding back of the BIC to contact the 
plasmalemma. Both the BIR and BIC are continuous (Fig. 2.12J) and absent from the 
apical end of the IMC (Fig. 2.12G).   
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2.2.7. IMC15 associates with the duplicated centrosomes and additional cytoskeletal 
structures 
ptub driven YFP-IMC15 localizes strongly to the budding IMC and weakly to the mature 
IMC like IMC3, 6, and 10 (Fig. 2.13A and C). It localizes to the apical cap like IMC11 
and the basal end like IMC5, 8, 9, and 13 (Fig. 2.13A and D). In addition IMC15 presents 
two novel spatial features by accumulating at the extreme apical end of the parasite and 
colocalizing with the centrosomes (Fig, 2.13A, D, E, F, and I). A ptub driven C-terminal 
fusion confirms its localization to the centrosomes and early buds, however its expression 
is faint and cortical localization is only clear in some parasites (Fig. 2.13B). When under 
its endogenous promoter IMC15 continues to localize to the centrosomes, budding 
daughters, and the extreme apical end of the parasite (Fig. 2.13H). The basal localization 
is greatly reduced and the cortical expression and cap expression are no longer present 
with the endogenous promoter. This could suggest that the latter two localization 
phenomena are the result of overexpression; however since the native expression level of 
IMC15 is extremely low (Fig. 2.4B), the lack of signal could be due to inadequate 
detection limits. Since expression at the extreme apical end is relatively intense, even 
under the native promoter, we tested if this expression corresponds to the conoid by co-
expresssing YFP-IMC15 with myc2-TgCentrin2, a protein present in the preconoidal ring 
(83). TgCentrin2 appears to be more apical than IMC15 and to be surrounded on the 
bottom by IMC15 (Fig. 2.13D). This indicates that the bright apical localization of 
IMC15 is in or around the conoid. 
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 The colocalization of IMC15 with the centrosomes is shown by the use of a 
centrin antibody (Fig. 2.13E, F, and I). It appears that IMC15 localizes to the 
centrosomes at the time of or immediately following their duplication. These spots 
become very intense before the signal transitions into the early buds, arching over the 
apical side of the centrosomes (Fig. 2.13E and F). Previous to this study the localization 
of MORN1 above the centrosomes was the earliest known marker of budding (82). 
However, relative to the weak MORN1 signal in very early buds, two very intense 
IMC15 bud structures are already visible (Fig. 2.13F). IMC15 localization to the 
centrosomes and early buds was confirmed with a specific antiserum raised against the 
N-terminus of IMC15 (Fig. 2.13G-I).  The antiserum does not recognize the apical 
accumulation, which is possibly due to post-translational modifications or to the YFP tag 
blocking the antibody recognition site.  Consistent with potential post-translational 
modification is the slower than expected migration of YFP-IMC15 fusion protein (Fig. 
2.7). 
 
2.2.8. The alveolin domain determines localization to the cortical or basal cytoskeleton 
Despite their variations in spatial and temporal dynamics, all of the IMCs can be divided 
into two general groups: those that are restricted to the mature basal cytoskeleton and 
those that are cortical. The localization of canonical intermediate filament proteins is 
governed primarily by their N- or C-termini because the central conserved domain is 
usually required for filament formation (84, 85). To test if this is true for the IMC 
proteins, we designed a series of deletion and chimeric constructs of IMC3 and IMC8. 
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Neither IMC3 nor IMC8 contain a predicted palmitoylation site that could potentially 
overrule amino acid motifs governing their localization (Fig. 2.3). For IMC3 the 
expression of the alveolin domain alone showed the same localization pattern as its full-
length counterpart (Fig. 2.14A). The results were the same for IMC8, except for the lack 
of pronounced basal localization in the buds when the alveolin domain is expressed alone 
(Fig. 2.14B). Additional deletion and chimeric constructs indicate that sequence is 
required on both ends of the alveolin domain to obtain the basal localization in the buds 
but the sequence does not have to be IMC8 specific (Fig. 2.14B, panels 5 and 6). These 
results suggest that, unlike conventional intermediate filaments, the alveolin domain is 
necessary for IMC3 and IMC8 localization and sufficient for IMC3 localization in a wild-
type background. 
 
2.3. Discussion 
Our data show that the 14 members of the Toxoplasma alveolin motif containing 
intermediate filament-like protein family have distinct spatial and temporal dynamics 
throughout tachyzoite development, including several phenomena not previously 
described. Based on our findings we established a development timeline outlined in 
Figure 2.15A. Formation of the daughter cytoskeleton begins with the localization of 
IMC15 to the centrosomes at approximately the time of duplication. All the other IMC 
proteins except IMC7, 12, and 14 assemble and grow with the daughter buds, with IMC3, 
6, and 10 exhibiting significant abundance in the daughter buds compared to the mature 
mother IMC. Halfway through daughter formation IMC5, 8, 9, and 13 shift their 
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localization to the basal complex and the basal complex starts to constrict (Fig. 2.12A). 
Completion of cytokinesis coincides with the appearance of three distinct regions within 
the basal complex (Fig. 2.15B). At this point IMC1, 3, 4, 6, 10, and 15 are present along 
the full length of the cortical cytoskeleton. IMC11 and 15 occupy the apical cap sub-
compartment of the IMC, and IMC15 is additionally observed at the very apical and basal 
ends of the IMC. Now in G1, IMC7, 12, and 14 begin to appear at the cortical IMC of the 
mature parasites. This series of events completes a full development cycle.  
The diverse behavior of the various IMC proteins can be accounted for with three 
factors: expression patterns, primary protein sequences, and post-translational 
modifications. The localization of IMC7, 12, and 14 exclusively to the mature 
cytoskeleton during G1 is supported by their expression profile, with IMC14 expression 
peaking about an hour after the majority of the IMCs and IMC7 and 12 peaking more 
toward the midpoint of G1 (Fig. 2.4B). The cortical vs. basal targeting of the proteins 
appears to be attributable to the primary protein sequence as we showed that the alveolin 
motif is a determinant for these patterns (Fig. 2.14). However, we cannot assert that 
variations in the alveolin domain sequences are the only factor in proper basal or cortical 
localization since other intermediate filament proteins first assemble into homo-dimers or 
-oligomers through their conserved regions before being targeted to the cytoskeleton (84, 
85). We can say that the alveolin domains are sufficiently distinct to allow the alveolin 
domain alone to oligomerize with the correct subgroup of untagged full-length native 
IMCs to be carried along to the appropriate location. Until the alveolin domains alone are 
shown to control the spatio-temporal patterns of the IMC proteins in gene-specific 
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knockout backgrounds it must be considered that localization information for the IMC 
proteins could be contained in the N- or C-terminal domains as well. Finally, though not 
specifically addressed in the preceding results, much of the observed IMC behavior could 
be attributed to post-translational modifications. A precedent for the importance of post-
translational modification is set by the proteolytic cleavage of IMC1 coinciding with a 
transition in filament skeleton rigidity (67). The smaller than expected bands for several 
IMC YFP fusion proteins in the western blots could be indicative of such proteolytic 
processing; however, at this point we cannot exclude the possibility that these sizes could 
originate in degradation during sample preparation (Fig. 2.7). In other intermediate 
protein filament systems assembly is controlled by post-translational modifications such 
as acylation and phosphorylation (84, 86). Several of the IMC proteins contain predicted 
palmitoylation sites (Fig. 2.3) and numerous potential phosphorylation sites (not shown).  
The appearance of IMC7, 12, and 14 in the G1 phase of the cell cycle (Fig. 2.9) is 
surprising as by G1 the daughters are mature and independent of the mother. The need for 
these additional cytoskeletal components is puzzling. One possible mechanism is that the 
G1 phase separates two subsequent cytokinetic events and these IMC proteins serve as 
markers to distinguish the mother cytoskeleton from future budding daughters. This 
model complements one of the most remarkable features of internal budding by 
Toxoplasma: it takes place in the presence of a mature mother cytoskeleton that at some 
point must be disassembled concurrently with the maturation of the daughters. Most 
Apicomplexa divide through schizogony wherein the mother’s IMC is disassembled long 
before new daughters are being assembled (87) and, thus, do not require features to 
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differentiate mother and daughter. The possibility of IMC7, 12, and14 playing the role of 
maturity marker is supported by the lack of orthologs in other apicomplexans (Table 2.3). 
The other cortical IMCs, IMC1, 3, 4, 6, and 10, which engage in the daughter budding 
process, are well conserved across the Apicomplexa (Table 2.3 and Fig. 2.16). 
IMC7, 12, and 14 may serve another function as well since they relocate back to 
the cytoplasm in most parasites after egress from the host cell (Tomasz Szetanek, Brooke 
Anderson-White, Michael White, Jeroen Saeij, and Marc-Jan Gubbels; paper under 
review). Inversely, the glycolytic enzyme aldolase-1 moves from the cytoplasm to the 
pellicle in extracellular parasites in response to the same changes in potassium and 
calcium concentrations (88) that induce egress (89-91). It is possible that IMC7, 12, and 
14 could be involved in the relocation of the glycolytic enzymes, involved in a signaling 
cascade upon egress and invasion as cytoplasmic IFs are involved in signaling (92), or 
these IMCs could provide a rigidity to the cytoskeleton that inhibits egress or invasion 
making their relocation to the cytoplasm necessary in extracellular parasites. 
The timing of the shift of IMC5, 8, 9, and 13 from the small buds to the basal 
complex is reminiscent of the timing of the previously described assembly of TgCentrin2 
on the basal complex, which marks the start of basal complex constriction to establish the 
tapered basal end of the cytoskeleton (Figs. 2.12A-C and 2.15A). TgCentrin2 has been 
suggested to provide the constrictive force (60). Daughter maturation and emergence 
coincides with relative localization shifts within the basal complex to generate three 
discernable regions that could coincide with the BIR and BIC revealed by EM (Fig. 
2.12H-J and 2.15B). Moreover, the BIC appears to bend over the alveoli and connect 
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with the plasma membrane, providing the only visible connection between the IMC and 
plasma membrane. However this bend is not observed at all times and could either be 
transient or be a transitional architecture in development. In addition to functioning in the 
constriction of the forming daughters, this complicated basal structure could assist in the 
maintenance of cellular integrity. Host cell invasion is accompanied by significant forces 
on the cytoskeleton when the parasite squeezes through a narrow aperture. Where the 
conoid reinforces the apical end, the basal complex could reinforce the basal end. Unlike 
MORN1, which is conserved across division modes in the Apicomplexa (87), the basal 
complex IMC proteins are not conserved among apicomplexans (Table 2.3). This lack of 
protein conservation is further supported by a lack of structural conservation. Though a 
posterior cup similar to Toxoplasma tachyzoites (28) is present in E. tenella merozoites 
(33), Plasmodium sporozoites contain a branching ER with a posterior polar ring that is 
not a clearly defined structure at their basal end (93).  
The contractile activity of these basal complex components is similar to the 
behavior of septins in other eukaryotes. Septins are actin and, in fission yeast, type II 
myosin dependent (94). However, in Toxoplasma actin disruption has no effect on 
parasite maturation (40). Myosin overexpression does have an effect on daughter bud 
maturation in Toxoplasma (41) but the myosin is highly divergent type XIV (42, 43). 
Furthermore, unlike in other eukaryotes, abscission is not complete in Toxoplasma, 
leaving the daughters connected by a cytoplasmic bridge until some form of mechanical 
stress breaks them apart (95). This suggests that a traditional septin apparatus is not 
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present in Toxoplasma. The basal IMCs could be part of an alternative mechanism that 
fulfills the same contractile role. 
IMC15 colocalizes with the centrosomes upon division and currently is the 
earliest known cytoskeletal marker for the new daughter buds, appearing earlier than 
MORN1 (Fig. 2.13). A potential model is that the centrosomal association of IMC15 
provides a cue for the start of daughter budding by recruiting MORN1 and the other IMC 
proteins. Regardless of the exact mechanism, IMC15 highlights a key step in the 
connection between the cell cycle and mitosis.  
Taken together, several IMC proteins are conserved, likely playing key roles in 
cytoskeleton assembly. However, expansion of the IMC protein family in Toxoplasma 
appears to have created new functions for several IMC proteins potentially not shared 
across the Apicomplexa. Future studies of these unique proteins could further elucidate 
the specific mechanisms of internal daughter budding.  
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Table 2.1. Reciprocal BLASTp results of all IMC proteins versus ToxoDB version 
4.3 
 
Both ToxoDB version 4 and version 5 gene names and IMC numbers are shown. Results 
up to an e-value = 10-3 cut-off value were reciprocally BLASTp searched and are shown. 
IMC proteins were numbered consecutively, first on basis of their discovery order and 
secondarily based on their ToxoDB sequence name. The unnumbered sequences 
presented BLASTp scores with an e-value within our arbitrary cut-off, but no alveolin 
motifs could be identified. Therefore, these are not considered to be part of the alveolin 
family and these genes were not pursued further in this study. 
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Table 2.1. Reciprocal BLASTp results of all IMC proteins versus ToxoDB version 4.3 
 
IMC ToxoDB                                                                                                                                     Identified by BLASTP Total 
 (TGME49) IMC1 IMC3 IMC4 IMC5 IMC6 IMC7 IMC8 IMC9 IMC10 IMC11 IMC12 IMC13 IMC14 IMC15 360 630 580 670 890 470 Hits 
IMC1 031640    X      X    X       3 
IMC3 016000 X  X X   X X  X  X X X       9 
IMC4 031630 X X  X X  X X X X X X X X       12 
IMC5 024530 X X X    X X  X  X X X X X X    12 
IMC6 020270 X  X     X X X  X         6 
IMC7 022220              X       1 
IMC8 024520 X X X X    X  X  X X X       9 
IMC9 026220 X X X X X  X  X X X X X X    X X  14 
IMC10 030210 X   X X   X  X  X         6 
IMC11 039770 X X X X X  X X X   X X X      X 12 
IMC12 048700   X                  1 
IMC13 053470 X X X X X  X X X X X  X X      X 13 
IMC14 060540 X X X X   X X X X  X  X       10 
IMC15 075670 X X X X   X X  X  X X        9 
-- 106360                     0 
-- 035630                     0 
-- 024580                     0 
-- 059670                     0 
-- 013890                     0 
-- 062470   X     X  X  X X X       6 
 Times Hit 11 8 11 10 5 0 8 11 6 12 3 11 9 11 1 1 1 1 1 2  
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Table 2.2. Yeast two-hybrid results of the basal complex components 
 
The basal IMC proteins, IMC5, 8, 9, 13 and 15, were all shown to interact with each 
other in yeast two-hybrid screens except IMC5 and 15. IMC9 was shown to only interact 
with IMC5 when used as the bait. Similarly, IMC15 was shown to only interact with 
IMC8 and 9 when used as the bait. These IMC interactions that produced different results 
when switched from bait to prey were verified in a second transformation. MORN1 and 
IMC3 were shown to interact with all the IMC proteins and TgCentrin2 was shown not to 
interact with them. Interactions were determined by growth on –Leu/-Trp/-His/-Ade 
(quadruple drop out or QDO) media. MORN1, IMC3, and TgCentrin2 were found to 
autoactivate as bait and, therefore, were only tested as prey. Abbreviations used are 
I+number for IMC proteins, whereas, M1 and C2 represent MORN1 and TgCentrin2, 
respectively. 
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Table. 2.2. Yeast two-hybrid results of the basal complex components 
 
 
___________________________________________________________ 
Bait     Prey 
        _________________________________________________ 
         I5  I8 I9 I13  I15 M1 I3 C2 
                    _________________________________________________ 
IMC5  + + + + - + + - 
IMC8  + + + + - + + - 
IMC9  - + + + - + + - 
IMC13 + + + + + + + - 
IMC15 - + + + + + + - 
___________________________________________________________ 
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Table 2.3. Conservation of IMC proteins across the Apicomplexa 
The T. gondii IMC proteins were BLASTp searched against the other apicomplexans 
with sequenced genomes (EuPathDB 2.12): Neospora caninum (ToxoDB 5.3), Eimeria 
tenella (GeneDB April 2008 release), Plasmodium falciparum (PlasmoDB V6.3), 
Plasmodium berghei (PlasmoDB V6.3), and Cryptosporidium parvum (CryptoDB V4.2). 
E-values of the top hits are shown. Bold numbers reflect significant homology hits. Note 
that not all top-hits were unique, as reflected in the total number of unique hits at the 
bottom. 
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Table 2.3. Conservation of IMC proteins across the Apicomplexa 
 
___________________________________________________________________ 
TgIMC N.can  E.ten  P.fal  P.ber  C.par 
___________________________________________________________________ 
1  E-186  E-135  E-71  E-69  E-35 
3  E-188  E-107  E-66  E-66  E-37 
4  E-174  E-141  E-94  E-93  E-47 
5  E-109  E-50  E-28  E-28  E-09 
6*  E-159  E-90  E-73  E-71  E-42 
7  E-149  E-02  E-16  E-11  E-02 
8  E-70  E-28  E-16  E-15  E-09 
9  E-188  E-60  E-21  E-21  E-35 
10  E-211  E-107  E-57  E-54  E-31 
11  E-64  E-20  E-19  E-18  E-10 
12  E-87  E-08  E-12  E-07  E-03 
13  E-120  E-51  E-23  E-22  E-44 
14  E-134  E-23  E-25  E-27  E-27 
15  E-130  E-25  E-41  E-41  E-19 
____________________________________________________________________ 
# unique 13  10  10  9  6 
IMCs 
____________________________________________________________________ 
* missing in T. gondii VEG strain 
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Figure 2.1. IMC3 is enriched in daughter buds and diminished upon maturation 
 
(A-B) Parasites at different developmental stages stained with IMC1 antibody show 
universal intensity distribution (A), whereas IMC3 antibody staining displays varying 
levels of intensity (B). (C) A merge of the red and green channel highlights the 
differences in IMC1 and IMC3 expression at the cortical IMC reinforcing that IMC3 is 
enriched in forming daughters and recently divided, newly emerged parasites. Parasite 
developmental stages are as indicated. (D) A merge image with DAPI staining (blue).   
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Figure 2.1. IMC3 is enriched in daughter buds and diminished upon maturation 
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Figure 2.2. Identification of IMC14 and 15 splice variants by RACE PCR 
 
(A) The 3’-end of the IMC14 mRNA was determined by RACE PCR using primers listed 
in Table 4.1. The IMC14 ORF was amplified from Prugniaud and RH strain cDNA using 
primers IMC14-F-Nhe and IMC14-R-RV. Three splice variants were detected in the 
Prugniaud strain (Pru14.1-3) and one in the RH strain. All four were different from each 
other and the predicted gene model (55.m04893). (B) Determination of IMC15 splicing 
by RACE (primers listed in Table 4.1) identifies a transcript deviating from the available 
gene models, in particular the 5’- and 3’-ends of the mRNA. The following IMC15 gene 
models, displayed in blue, were used from the top down: 64.m00327, TgTwinScan_1698, 
TgTigrScan_7407, TgGLEAN_0852 and TgGlmHMM_1748. Solid boxes represent the 
coding sequence. The models used throughout the study are marked with an asterisk 
(IMC14.RH and RACE validated IMC15). 
 
 
 46 
Figure 2.2. Identification of IMC14 and 15 splice variants by RACE PCR 
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Figure 2.3. Alveolin domain-containing IMC protein family 
 
Full-length and validated open reading frames of each IMC protein in order by IMC 
number and their corresponding ToxoDB gene name. The alveolin repeat regions are 
represented in yellow and the N- and C-termini in green. Cysteines are indicated in red 
and predicted palmytoylation sites marked with blue asterisks. 
 
 48 
Figure 2.3. Alveolin domain-containing IMC protein family 
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Figure 2.4. Expression of IMC proteins during tachyzoite development 
 
(A) Affymetrix array expression pattern of the IMC mRNAs through two cycles of 
tachyzoite development. RH strain parasites expressing the herpes simplex thymidine 
kinase (TK) were synchronized by a thymidine block. Cell cycle stages and timing of 
budding are indicated at the top. Expression levels are normalized to internal controls on 
the Affymetrix array. (B) Maximum and minimum expression levels of the IMC genes in 
the second cycle represented in (A) (hours 6–12). Expression level is shown as the raw 
fluorescence hybridization data. 
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Figure 2.4. Expression of IMC proteins during tachyzoite development 
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Figure 2.5. Localization of IMC1 and IMC3 throughout tachyzoite development 
 
(A-B) Mature (A) and budding (B) parasites co-stained with antibodies against IMC1 
(green) and IMC3 (red). (C) Intensity profile across the budding daughters indicated in 
(B) panel 3 marked by arrow “C”. Relative distance is shown along the length and 
direction of the arrow on the x-axis and relative intensity is shown on the y-axis. 
Arrowheads indicate specific localization of IMC1 in the mature mother parasites not 
detected for IMC3. (D) Mature mother intensity profile along the arrow indicated in (C) 
panel 3 marked with “D”. (E) IMC1-YFP expressing parasites are stained with IMC1 
antibody (red) validating the interchangeable use of the fusion and antibody. The YFP tag 
does not appear to interfere with the localization pattern of IMC1. (F) Comparable results 
are obtained for YFP-IMC3 (green) and the IMC3 antibody (red). All YFP constructs are 
driven by the ptub promoter. 
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Figure 2.5. Localization of IMC1 and IMC3 throughout tachyzoite development 
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Figure 2.6. Relative localization of IMC4 throughout tachyzoite development 
 
(A) Parasites expressing YFP-IMC4 (green) co-stained with IMC1 antibody (red) show 
equal intensity of IMC1 and IMC4 across development stages. (B) Parasites expressing 
YFP-IMC4 (green) co-stained with IMC3 antibody (red) show equal intensity of IMC4 
across developmental stages, whereas IMC3 is enriched in the budding daughters. (C) 
Live imaging of stable parasites expressing IMC4-YFP corroborate the localization 
pattern observed with an N-terminal fusion. All YFP constructs are driven by the ptub 
promoter. 
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Figure 2.6. Relative localization of IMC4 throughout tachyzoite development 
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Figure 2.7. Verification of N-terminal YFP fusions with western blot 
 
The expected masses of the IMC proteins plus the YFP tags are indicated at the bottom of 
each lane. Full-length fusions are marked with an asterisk (*) and smaller products of 
cleavage or degradation events are marked with a plus (+). The smaller product observed 
for IMC7 appears to be the YFP tag alone (27 kDa). For IMC14 a full-length band of the 
expected size is not present. Since these blots were performed using only mature parasites 
the data could suggest that all IMC14 is cleaved during the maturation process. IMC15 
displays 2 bands slightly larger than the expected full-length fusion, which hint at 
potential post-translational modifications.    
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Figure 2.7. Verification of N-terminal YFP fusions with western blot 
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Figure 2.8. Relative localization of IMC6 and IMC10 throughout tachyzoite 
development 
 
(A-B) Mature (A) and budding (B) parasites expressing YFP-IMC6 co-stained with 
IMC3 antibody (red). (C) Intensity profile across the budding daughters indicated in (B) 
panel 3 marked by arrow “C”. Relative distance is shown along the length and direction 
of the arrow on the x-axis and relative intensity is shown on the y-axis. (D-E) Live 
images of YFP-IMC6 (D) and IMC6-YFP (E). (F-G) Mature (F) and budding (G) 
parasites expressing YFP-IMC10 co-stained with IMC3 antibody (red). (H) Intensity 
profile across the budding daughters indicated in (G) panel 3 marked by arrow “H”. (I-J) 
Live images of YFP-IMC10 (I) and IMC10-YFP (J). All YFP constructs are driven by 
the ptub promoter. 
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Figure 2.8. Relative localization of IMC6 and IMC10 throughout tachyzoite 
development 
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Figure 2.9. IMC7, 12, and 14 are excluded from the budding cytoskeleton 
 
 (A-C) Mature (A), mid-budding (B), and emerging (C) parasites expressing YFP-IMC7 
co-stained with IMC3 antibody (red). (D) YFP-IMC7 expressing parasites co-stained 
with GAP45 antibody (red). (E) Intensity profile across the budding daughter indicated in 
(B) panel 3 marked by arrow “E”. Relative distance is shown along the length and 
direction of the arrow on the x-axis and relative intensity is shown on the y-axis. (F) Live 
images of IMC7-YFP. (G-H) Mid-budding (G) and emerging (H) parasites expressing 
YFP-IMC12 co-stained with IMC3 antibody (red). (I) YFP-IMC12 expressing parasites 
co-stained with GAP45 antibody (red). (J) Live images of YFP-IMC12 driven by its 
native promoter. (K) Live images of IMC12-YFP driven by its native promoter. (L) 
Intensity profile across the budding daughter indicated in (G) panel 3 marked by arrow 
“L”. (M) Live images of IMC12-YFP. (N-P) Mature (N), mid-budding (O), and emerging 
(P) parasites expressing YFP-IMC14 co-stained with IMC3 antibody (red). (Q) Intensity 
profile across the budding daughter indicated in (O) panel 3 marked by arrow “Q”. (R) 
YFP-IMC14 expressing parasites co-stained with GAP45 antibody (red). All IMC7 and 
14 YFP-fusion constructs are driven by their native promoters and all IMC12 YFP-fusion 
constructs are driven by the ptub promoter except for (J) and (K). 
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Figure 2.9. IMC7, 12, and 14 are excluded from the budding cytoskeleton 
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Figure 2.10. IMC7, 12, and 14 transition to the mature cytoskeleton during G1 
 
(A) Selected frames from time-lapse images of YFP-IMC12. (B-C) CherryRFP-IMC7 
(B) and CherryRFP-IMC14 (C) expressing parasites stained with cherryRFP antibodies 
exhibiting cortical and cytoplasmic localization. (D) FV-P6 expressing CherryRFP-IMC7 
or CherryRFP-IMC14 were allowed to replicate for 18 hrs at 35°C before transition to 
40°C (controls were kept at 35°C). After 16 hrs the localization of IMC7 and IMC14 was 
differentiated between cytoplasmic or cortical. The percentage of vacuoles with cortical 
signals is plotted for the conditions as indicated. (E) As in (D) except that the parasites 
were allowed to invade and grow at 40°C for 16 hrs (all parasites arrest before division). 
Results from three independent experiments and error bars denote standard deviation. 
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Figure 2.10. IMC7, 12, and 14 transition to the mature cytoskeleton during G1 
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Figure 2.11. IMC11 localizes to the apical cap and colocalizes with PhIL1 
 
(A-B) Live mature (A) and budding daughter (B) parasites expressing YFP-IMC11. The 
timing of the shift from full cortical IMC expression in the buds to apical cap and basal 
localization is unknown. Arrowheads indicate YFP localization at the basal complex. (C) 
Live YFP-IMC11 (green) expressing parasites co-transfected with PhIL1-CherryRFP 
(red). (D) YFP-IMC11 expressing parasites co-stained with MORN1 antibodies (red) and 
DAPI (blue). YFP-IMC11 is driven by the ptub promoter. 
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Figure 2.11. IMC11 localizes to the apical cap and colocalizes with PhIL1 
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Figure 2.12. IMC5, 8, 9, and 13 localize to the budding daughters and then 
transition to the basal complex 
 
(A) Live YFP-IMC8 expressing parasites at different stages of tachyzoite development 
(independent parasites are shown in each panel). Mother and daughter parasites are traced 
by dotted lines in the lower series. (B) Live images of IMC13-YFP. (C) DD-YFP-IMC5 
expressing parasites are stained with IMC5 antibody (red) validating the interchangeable 
use of the fusion and antibody. The DD-YFP tag does not appear to interfere with the 
localization pattern of IMC5. (D) Wild-type parasites co-stained with anti-IMC5 serum 
(red), IMC1 antibodies (green), and DAPI (blue). (E) Wild-type parasites co-stained with 
anti-IMC5 serum (red), MORN1 antibodies (green), and DAPI (blue). (F) Pair-wise 
comparisons of the members of the basal complex using co-transfected YFP and 
CherryRFP constructs. The numbers represent the tagged IMC protein, M1 is MORN1, 
C2 is TgCentrin2, and the colors correspond with the fluorescent protein fusion. The 
asterisks in the MORN1 + IMC9 panel mark the spindle pole localization of MORN1. All 
YFP and DDYFP constructs are driven by the ptub promoter. (G-J) Electron micrographs 
identifying an inner collar at the basal end of the cytoskeleton. (G) Cross section through 
the apical complex demonstrating the absence of a comparable complex at the apical end. 
(H) Longitudinal section through the posterior end of a parasite displaying the basal inner 
collar (BIC) and the fold over the alveoli marked with arrowheads. The arrows mark the 
end of the alveolar vesicles. A unit membrane (UM) of unknown origin with an electron 
dense coating that is limited to the basal cup region is visible as a clear vesicle sitting 
within the very basal opening. (I) Longitudinal section through the basal complex. 
Arrowheads mark the BIC, which bends over the end of the alveolar membrane and 
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connects with the plasma membrane as indicated by the arrow. The area marked by the 
blue box is enlarged. (J) A transverse section through the basal complex displaying the 
continuity of the BIC and basal inner ring (BIR), which are visible in the enlarged area 
marked by the blue box. In addition, the two closely apposed UMs can be discerned. P is 
plasma membrane. EM images provided by Dr. David J. P. Ferguson, University of 
Oxford. 
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Figure 2.12. IMC5, 8, 9, and 13 localize to the budding daughters and then 
transition to the basal complex 
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Figure 2.13. IMC15 associates with the duplicated centrosomes and transitions to 
the budding cytoskeleton 
 
(A) Live mature and budding daughter parasites expressing YFP-IMC15. An arrow 
indicates the very basal end of the cytoskeleton, an arrowhead the very apical end, and 
the double arrowheads the cap region. (B) IMC15-YFP stained with anti-GFP. (C) YFP-
IMC15 expressing parasites co-stained with IMC3 antibody (red) in mid-budding 
parasites. (D) YFP-IMC15 expressing parasites co-expressing myc2-centrin2 and stained 
with myc antibody (red) in early budding parasites. Arrowheads indicate the very apical 
end of the parasite, double arrowheads the apical cap ringed by six TgCentrin2 foci, 
single arrow the very basal end, and double-headed arrows the early bud. Inset is of 
boxed area. (E) YFP-IMC15 expressing parasites co-stained with anti-human centrin 
antibody (red) in mature parasites. Arrows mark IMC15 localization to the duplicated 
centrosomes. Inset is of boxed area. (F) YFP-IMC15 expressing parasites co-transfected 
with cherryRFP-MORN1 (red) and co-stained with anti-human centrin antibody (blue) in 
very early budding parasites (pre-mitotic as indicated by the single, centrally located 
MORN1 accumulation highlighting the spindle pole). The parasite is outlined with a 
dotted line in the first panel.  Insets are of the central region around MORN1. (G) YFP-
IMC15 expressing parasites are stained with IMC15 antibody (red). The antibody 
recognizes only the budding aspects of the localization pattern of YFP-IMC15. (H) The 
same results are obtained with YFP-IMC15 under control of its native promoter. (I) S-
phase wild-type parasites stained with anti-IMC15 serum (red) and co-stained with 
centrin antibody (green) and DAPI (blue).  All insets are 2X enlargments.  All YFP 
constructs are driven by the ptub promoter except (H). 
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Figure 2.13. IMC15 associates with the duplicated centrosomes and transitions to 
the budding cytoskeleton 
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Figure 2.14. The alveolin domain contains the localization signal differentiating 
cortical from basal IMCs 
 
(A-B) IMC3 (A) and IMC8 (B) are dissected to determine whether the N-terminus (“N”), 
alveolin domain (“A”), or C-terminus (“C”) is/are responsible for their localization 
patterns. The domains indicated above or below each panel are fused to an N-terminal 
YFP and all constructs are driven by the ptub promoter. IMC3 domains are in blue and 
IMC8 domains are in green. 
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Figure 2.14. The alveolin domain contains the localization signal differentiating 
cortical from basal IMCs 
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Figure 2.15. Summarizing schematics of the IMC protein dynamics throughout 
tachyzoite development and the structure of the basal cytoskeleton 
 
(A) Groups of IMC proteins with a similar behavior are shown in the same color and the 
groups are introduced at the stage of their defining role; among the yellow, cortical IMC 
proteins, the ones with a preference for the immature buds are outlined (IMC3, 6, and10). 
IMC11 is not included. (B) The tentative structure of the basal complex in mature 
parasites is composed of three layers. The top layer (green) is composed of MORN1, 
IMC9, IMC13, and IMC15; the middle layer of IMC5 and 8; and the very basal tip 
contains TgCentrin2, which overlaps with the middle layer. Data in Figure 2.12F do not 
include clear candidates for the bend of the inner collar toward the plasma membrane 
seen by EM (Fig. 2.12H-J). Interpretation of the posterior cup is based on data presented 
in (28). 
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Figure 2.15. Summarizing schematics of the IMC protein dynamics throughout 
tachyzoite development and the structure of the basal cytoskeleton 
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Figure 2.16. Tree of IMC proteins and their closest apicomplexan relatives 
Phylogenic tree with 1000x bootstrapping of the top BLASTp results from Table 2.3. 
Blue circles at the nodes indicate bootstrap values of greater than or equal to 50.  Red 
circles at the nodes indicate bootstrap values of greater than or equal to 80. 
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Figure 2.16. Alignment of IMC proteins and their closest apicomplexan relatives 
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Chapter 3. Analysis of the role of IMC15 in early cytoskeletal development 
 77 
3.1. Introduction 
The destructive, rapid replication of Toxoplasma occurs by an internal budding 
mechanism that begins with the division of the Golgi and the duplication of the 
centrosome (17, 23-25, 29). Concurrent with or immediately following the duplication of 
the centrosome the earliest components of the cytoskeleton begin to form near the two 
centrosomes. The first of these components is IMC15. As the initial member of the IMC 
meshwork to appear in division it is possible that IMC15 nucleates the development of 
this IMC structure.   
 Precedents exist for the importance of early bud constituents in Toxoplasma. 
Another early indicator of cytoskeletal budding is Rab11B, a small GTPase that traffics 
the vesicles of the IMC. Conditional expression of a dominant-negative Rab11B 
construct blocks IMC biogenesis (13). Moreover, the absence of ISP2, a component of 
the central region of the IMC not imbedded in the IMC meshwork, results in a 
multinucleated mass containing several stunted early bud formations (14). Disrupting the 
proteins of the early buds does not always result in a defect early in the division process, 
as exemplified by MORN1. MORN1 deletion mutants develop normally until the 
midway point and then basal constriction and basal complex formation are abnormal (11) 
or cytokinesis fails to occur (10). Not only are these foremost budding factors essential 
for proper parasite development, but the effects of their loss are not limited to the 
inaugural stages of development.   
In this chapter, I identified the homologs of IMC15 in other apicomplexan species 
and performed detergent extractions to verify that IMC15 exists within the IMC 
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meshwork. While delving more deeply into the function of IMC15, the inability to 
generate a direct knockout (KO) suggests this protein is essential. Furthermore, 
conditional knockouts using two different systems show that a minimal amount of IMC15 
is sufficient to maintain parasite viability. Deletion constructs of IMC15 expressed in a 
wild-type background suggest that the localization of IMC15 is controlled by multiple 
factors beyond the sequence of the alveolin domain. Furthermore, the overexpression of 
the C-terminus appears to elicit a dominant negative effect. Constructs with 
palmitoylation site point mutations also suggest a prominent role for the C-terminus in 
proper development and support the possibility of a complex palmitoylation system in 
Toxoplasma. Characterization of IMC15 is continuing to provide novel insight into 
cytoskeletal development.   
 
3.2. Results 
 
3.2.1. Identification of IMC15 homologs in apicomplexans 
 
Previous work with the IMC family focused on identifying all the related proteins within 
the Toxoplasma genome (96). To assess the relationship of IMC15 (TGGTI_000660) to 
other apicomplexans, BLASTp searches of the sequenced genomes in EuPathDB version 
2.10 were performed as well as BLASTp searches in NCBI (97). Of those proteins with 
an EuPathDB e-value of -40 or less, 9 out of 10 appear in both result sets. These 10 hits 
were BLAST searched against ToxoDB and for all 10 IMC15 is the closest match (75). 
All BLAST results are presented in Table 3.1. 
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Alignment of IMC15 with the 10 homologs with the lowest e-values reveals that 
the N- and C-termini exhibit limited intergenus similarity (Fig. 3.1). However the 
alveolin repeat region (312-602 aa) shows high homology (Fig. 3.2A). As illustrated by 
the phylogenic tree generated from the full-length homolog sequences in Figure 3.2B, 
IMC15 is most closely related to its homolog in Neospora and closely followed by those 
in Babesia and Theileria.  The distance of the Plasmodium homologs from Toxoplasma 
IMC15 could be attributed to the more conserved terminal regions amongst Plasmodium 
species (Fig. 3.1); however, a phylogenic tree comparing only the alveolin domains 
reveals the same relationships as the full-length sequences. Based on the alignments, the 
predicted palmitoylation sites discussed in Chapter 2 at cysteines 4, 92, 93, 673, and 674 
(Fig. 2.3) are not conserved (Fig. 3.1). However, several potential phosphorylation sites 
exist within the conserved alveolin domain (Fig. 3.2A). 
 
3.2.2. IMC15 is part of the IMC meshwork 
IMC15 displays a unique spatio-temporal localization pattern during budding, appearing 
with the duplication of the centrosomes and then expanding to colocalize with the early 
MORN1 rings. IMC15 localizes to the developing IMC of the new daughters but its 
cortical intensity diminishes until it is undetectable as the daughters mature when 
visualized with our IMC15 antibody (96). Components of the mature IMC are known to 
be insoluble in 1% Triton X-100 (TX-100) and 1% deoxycholic acid (DOC) (28). To 
verify that IMC15, an alveolin repeat containing protein, is part of the IMC meshwork of 
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the mature cytoskeleton, detergent extractions were performed. For this we used an 
endogenously tagged version of IMC15, IMC15-myc3 (Fig. 3.3A).   
 As shown in Figure 3.4, IMC15 is an insoluble component of the cytoskeleton, 
appearing in the pellet fractions with IMC1. These results with mature extracellular 
parasites verify that IMC15 is part of the mature cytoskeleton. The extremely low 
expression level of IMC15 (Fig. 2.4B) prohibits us from collecting enough material from 
the daughter buds to examine the solubility of IMC15 in the immature cytoskeleton by 
western blot (96). It does not appear, based on the mature-only lysate, that IMC15 
undergoes a cleavage event like IMC1 upon cytoskeletal maturation (67).  
 
3.2.3. Resistance to KO suggests IMC15 is essential 
Toxoplasma exhibits a strong preference for non-homologous end-joining (NHEJ) over 
homologous recombination (HR) and this preference is an obstacle for the efficient 
generation of KOs (98-102). Ku80 is an essential element of the NHEJ machinery (103, 
104) that when eliminated can shift an organism’s preference to HR over NHEJ and 
increase the efficiency of KO generation (105-110). In order to decrease the barrier to 
KO creation and, thus, increase our tools to study gene function in Toxoplasma, a parasite 
strain lacking the ku80 gene, the Δku80 strain, was engineered (111, 112). To begin 
characterizing the function of IMC15 we undertook to generate a KO using the Δku80 
strain.  
 Multiple attempts to remove imc15 by replacing the gene with HXGPRT were 
unsuccessful (Fig. 3.3B). Instead of double HR to remove the gene it provided single HR 
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or reinsertion of the knocked out region despite the absence of Ku80. The inability to 
create a KO suggests that IMC15 may be essential. 
  
3.2.4. IMC15 strongly associates with the centrosome 
The function of essential genes can be studied with a conditional knockdown (KD) so we 
created a conditional construct of IMC15 using the destabilization domain (DD) system 
(45, 113). A DDmyc-IMC15 construct under the control of pimc15 was knocked into the 
uracil phosphoribosyltransferase (UPRT) locus to allow for negative selection with 5-
fluorodeoxyuridine (FUDR) (Fig. 3.3C) (114-116) and subsequently the entire locus of 
IMC15 was knocked out using the direct KO strategy (Fig. 3.3B). The resultant 
transgenic strain is cultured continuously in the presence of the synthetic ligand, Shld1, 
which stabilizes the DD-tagged protein. When Shld1 is removed the DDmyc-IMC15 
should be targeted to the proteasome and degraded.  
 DDmyc-IMC15 localizes normally while cultured with Shld1, appearing with the 
duplicated centrosomes (Fig. 3.5A) and then expanding into the early buds (Fig. 3.5B and 
C). When Shld1 is removed we do not observe a loss of IMC15 (Fig. 3.5D) but instead 
the protein remains tightly locked with the centrosomes throughout budding. Unlike wild-
type, IMC15 no longer enters the buds in the absence of Shld1, at least not at a level 
detectable by IFA (Fig. 3.5E and F); however, these parasites are viable through several 
passages and exhibit no obvious phenotype. Since the DD system controls protein levels 
post-translationally, the tagged protein under the control of its native promoter continues 
to be expressed at normal levels and if it has a strong targeting signal or high affinity for 
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a specific cellular structure it is possible it will not be efficiently regulated by the 
proteasome. This could be the case for DD-controlled IMC15.  
 
3.2.5. Minimal levels of IMC15 sufficient for parasite viability  
Since conditional regulation of IMC15 post-translationally is not optimal, we tried an 
alternative method that employs a tetracycline (tet) repressible promoter to control 
protein expression at the level of transcription (117, 118). Working with a strain of Δku80 
parasites that also expresses the tetracycline transactivator, TATiΔku80 (Drs. Lilach 
Sheiner and Boris Striepen; unpublished), we directly replaced the promoter of IMC15 
with seven tet-operator repeats followed by one of two minimal SAG promoters, pT7S4 
(minimal SAG4 promoter) or pT7S1 (minimal SAG1 promoter) (Fig. 3.3D) (117, 118). 
With the addition of anhydrous tetracycline (ATc) to either strain IMC15 expression 
should be reduced to minimal levels.  
 When different clones of the pT7S4 promoter replacement strain were exposed to 
ATc and their viability assessed by plaque assay, a reduction in plaque size was observed 
for all clones. However, we did not not observe the complete cessation of growth we 
expected from minimization of an essential gene (Fig. 3.6A). The SAG4 minimal 
promoter does not completely abolish transcription of the gene; therefore, it is possible 
that the minimal amount of resultant protein expression is enough to satisfy the needs of 
the parasite. To further reduce the minimal expression of IMC15, the weaker SAG1 
promoter was switched for the SAG4 promoter. Plaque assays were performed with three 
different clones of the pT7S1 promoter KO strain. We observe a reduction in plaque 
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number and size that is more severe than with pT7S4, but again growth is not abolished 
(Fig. 3.6B). When the pT7S1 controlled parasites (clone H2) are exposed to ATc for up to 
four days, IMC15 is still visible by IFA with anti-IMC15. These results, combined with 
the already low native expression level of IMC15 (Fig. 2.4B), and the DDmyc-IMC15 
results suggest that extremely low levels of IMC15 are enough for parasite survival. 
 
3.2.6. IMC15 deletions suggest importance of the C-terminus 
Despite the lack of a KO background we can begin to determine what regions of IMC15 
are necessary for proper protein function. We approached this in the same manner as with 
the IMC3 and IMC8 deletions discussed in Chapter 2. Each region of IMC15, the N-
terminus, alveolin domain, and C-terminus, were expressed individually as N-terminal 
YFP fusions and then as pairs. In transient transfections all constructs localize like wild-
type; some have more cytosplasmic localization than others and some are more faint at 
the apical and basal ends, but they all follow the wild-type pattern. However, the 
constructs that contain the C-terminus, except for full-length IMC15, cannot be supported 
by the parasite long-term. The inability to integrate these constructs into a stable line may 
suggest an important role for the C-terminus that is interrupted by overexpression.   
 
3.2.7. IMC15 palmitoylation mutants may exert dominant negative effect 
Palmitoylation has been proven necessary for the assembly of the apicomplexan 
glideosome (44, 65, 119) as well as the components of the Toxoplasma IMC (14). IMC15 
has five cysteines that are strongly predicted to be palmitoylated (Fig. 2.3). Three of these 
 84 
sites are in the N-terminus and two are in the C-terminus. Since the deletion constructs 
suggest more complex localization mechanisms for IMC15 than simply the sequence of 
the alveolin domain, these predicted palmitoylation sites might be important. To examine 
if any of these cysteines are involved in proper IMC15 localization they were each 
mutated individually (sequential predictions were treated as one site and mutated 
together): Cys 4 to Ala (C4A), Cys 92 and 93 to Ala (C92A/C93A), and Cys 673 and 674 
to Ala (C673A/C674A); followed by mutated in pairs; and then finally all mutated at 
once. All mutants were then cloned as N-terminal YFP-fusions. 
 As with the deletion constructs, all of these mutants localize like wild-type in 
transient transfection in wild-type parasites. However, three of the constructs 
(C673A/C674A, C4A.C92A/C93A, and C4A.C673A/C674A) exhibit extremely low 
transfection efficiencies (< 10%) and the constructs did not produce stable lines despite 
multiple attempts (Fig. 3.7). Inclusion of the C-terminal potential palmitoylation sites in 
two of these constructs supports the possible importance of the C-terminus to proper 
IMC15 function. Most importantly these constructs could be exerting a dominant 
negative effect.  
 
3.3. Discussion 
IMC15, the earliest cytoskeletal component of daughter budding in Toxoplasma, is well 
conserved across apicomplexans (Table 3.1 and Fig. 3.1 and 3.2). This protein is 
insoluble in 1% TritonX-100 and 1% DOC verifying that it is part of the non-extractable 
cytoskeleton and more specifically the IMC protein meshwork (Fig. 3.4). IMC15 has thus 
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far proven resistant to direct KO. However, the locus is accessible and removable by the 
described method as it can be knocked out when IMC15 is ectopically expressed, as in 
the DD-IMC15 controlled KD. This suggests IMC15 is essential. The conditional KD 
using the DD system indicates that IMC15 may not be necessary in the early bud and its 
primary role could occur during the period of colocalization with the centrosomes (Fig. 
3.5). Furthermore the results of a conditional KD with the tet repressible promoter 
indicate that the parasite requires very little IMC15 to remain viable (Fig. 3.6). Deletion 
constructs of and mutations at predicted palmitoylation sites in IMC15 suggest the C-
terminus may be important for proper IMC15 function and overexpression. The suspected 
dominant negative effect of some of these potential palmitoylation and deletion mutants 
may be sufficient to further characterize IMC15 behavior.  
 The conservation of IMC15 across apicomplexans is intriguing since division 
modes vary throughout the Apicomplexa family as discussed in Section 2.3. MORN1 is 
another essential protein involved in the development of the Toxoplasma cytoskeleton 
that is conserved throughout apicomplexan species and between endodyogeny, 
endopolygeny, and schizogony (95). The primary role of MORN1 appears to occur later 
in the division process (10, 11), whereas we hypothesize the primary role of IMC15 
occurs earlier, perhaps linked with the newly duplicated centrosomes. Fortunately, 
centrosomes in Sarcocystis and centriolar plaques in Plasmodium, though not as well 
studied, appear to fulfill similar important niches in endopolygeny (120) and schizogony 
(121) as in endodyogeny (24, 25, 29).  
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 When IMC15 is overexpressed as a N-terminal YFP fusion we observe clear 
localization of IMC15 to the mature, cortical IMC (Fig. 2.13); however, when native 
IMC15 is visualized with antiserum the cortical localization cannot be detected (Fig. 
2.13I). Detergent extractions on fully mature parasites show IMC15 to be insoluble under 
the conditions used to isolate the cytoskeleton and, therefore, it is part of the cortical IMC 
or the basal complex (28) (Fig. 3.4). The ability of the IMC15 antibody to recognize the 
brightest accumulations of IMC15 in the centrosomes and the early buds and the inability 
of the IMC15 antibody to recognize the cortical IMC15 suggests a high detection limit 
for the antibody. The only intense IMC15 structure seen with the YFP-fusions and not 
with the antibody is the small ring at the apical end (Fig. 2.13G and H). Since the IMC15 
antibody was raised against the N-terminal region of the protein it is possible that this 
region is not accessible to the antibody when in that structure. The detergent extractions 
did not suggest that IMC15 undergoes a cleavage event similar to IMC1 (67), but further 
experiments would be necessary to verify the absence of such an event.  
 The inability to KO this potentially essential gene led us to develop two 
conditional KDs using the DD system and the tet repressible promoter. Though neither 
system sufficiently downregulated IMC15 to produce a useful KO-like background (Fig. 
3.5 and 3.6) we were able to extract information from these conditional strains. First, 
IMC15 has a strong affinity for the centrosomes. Whether this affinity is the result of a 
targeting sequence, a post-translational modification, and/or tight protein-protein 
interactions remains to be determined. Since IMC15 does not transition from the 
centrosomes to the early buds, at least not in levels detectable with anti-IMC15, and the 
 87 
parasites are viable for several passages in the DD conditional KD without Shld1, the 
primary function of IMC15 could be at the earliest stages of mitosis with the duplicated 
centrosomes (24, 25, 29). Finally, a minimal level of IMC15 transcription is sufficient for 
parasite survival so any other KD system will not provide a satisfactory downregulation 
of IMC15 for further functional studies. A conditional KO using the Cre-Lox system 
(122-124) or a dominant negative construct are alternative options.  
 Mutation of potential palmitoylation sites in three combinations, C673A/C674A, 
C4A.C673A/C674A, and C4A.C92A/C93A, may offer the dominant negative effect 
necessary to further characterize IMC15. The low transfection efficiencies of these 
mutants and the inability to form stable lines with them suggests they are toxic. C673 and 
C674 are in the C-terminus of IMC15 and their mutation alone disrupts the parasite 
suggesting an important role for the C-terminus in IMC15 behavior. However, the 
mutation of these C-terminal sites along with C92 and C93 of the N-terminus and the 
mutation of all of the potential palmitoylation sites at once do not exhibit any obvious 
deleterious effects. It is possible that the mutation of all of the predicted palmitoylation 
sites renders the protein in an inert-like state where it can potentially dimerize with the 
native IMC15 and be carried along to the proper sub-compartments of the parasite. The 
possibility that the sites must be palmitoylated in a specific sequence should be 
considered as an explanation for the other results. Furthermore, a complex system of 
palmitoyl acyltransferases (PATs) has been proposed in Toxoplasma that could affect 
these mutants (14). The palimitoylation of IMC15 remains to be verified to support that 
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the observed effects result from a lack of palmitoylation and not from misfolding due to 
the substitution of an Ala for a Cys. 
 The importance of the C-terminus suggested by the potential palmitoylation 
mutants is supported by the results of the deletion constructs. Only those constructs that 
contain the C-terminus, IMC15C, IMC15AC, and IMC15NC, did not become stable 
when overexpressed as YFP-fusions. Furthermore, unlike the results for IMC3 and IMC8 
(Section 2.2.8), the alveolin domain was not shown to be necessary or sufficient for 
IMC15 localization. IMC3 and IMC8 were originally selected for the deletion and 
chimera project because they lack predicted palmitoylation sites; therefore it is quite 
reasonable that palmitoylation affects the behavior of IMC15.   
 In addition to palmitoylation, phosphorylation could contribute significantly to the 
behavior of IMC15. Phosphoylation plays a major role in the regulation of classical 
intermediate filaments (125) and in the development of the Toxoplasma cytoskeleton-
associated glideosome (126). When the apicomplexan homologs of IMC15 are aligned 
there are five conserved sites in the alveolin domain: Thr 419, Ser 545, Ser 547, Thr 352, 
and Ser 386. In the N-terminus there is a potential NIMA kinase site, Ser 254, that is of 
interest but is not conserved (127) (Fig.3.1 and Fig. 3.2A). Mutations of these sites could 
produce dominant-negative effects as well.   
 It was proposed in Section 2.3 that the basal IMCs appear to fulfill a similar role 
to the septins of other eukaryotic organisms during cytokinesis. More generally septins 
oligermerize to create filaments that organize into membrane-associated cytoskeletal 
scaffolds and arrange to demarcate subcellular compartments (94). This description 
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suggests that the entire IMC family is septin-like. Before cytokinesis a conserved protein, 
anillin, nucleates the formation of septins at the contractile ring in the same way we 
hypothesize IMC15 nucleates the formation of the IMC cytoskeleton (128). Anillin does 
not remain in the cytoskeleton but relocates to the nucleus during interphase in most 
organisms. It does not form filaments itself and is actin dependent (128). As with the 
basal IMCs and septins, IMC15 is not a traditional anillin protein and no anillin homolog 
is present in the Toxoplasma genome. Even though IMC15 and the IMC family are not 
canonical anillin and septins, they are possibly fulfilling the analogous functions of 
anillin and septins in the non-actin based cytoskeleton of Toxoplasma.  
 IMC15 is the earliest component of the Toxoplasma cytoskeleton to indicate the 
initiation of daughter bud formation. The unique mechanisms of daughter bud formation 
are poorly understood and continued functional analysis of IMC15 is providing novel 
insight into the early stages of this process.  
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Table 3.1. IMC15 BLASTp searches identify several apicomlexan homologs 
 
EuPathDB results for BLASTp searches with the IMC15 sequence are shown with a cut-
off e-value of 10-20. The next highest score is another Toxoplasma IMC protein. The cut-
off e-value for the NCBI searches is 10-32 for the same reason. Those proteins identified 
in both searches and with an EuPathDB score less than 10-40 were reciprocally BLAST 
searched in ToxoDB and the e-value for IMC15 in their results recorded. IMC15 was the 
top hit for all proteins. IMC15 matches to itself with an e-value of greater than 0 in the 
EuPathDB and ToxoDB searches because the databases have not been updated with the 
correct published annotation.   
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Table 3.1 IMC15 BLASTp searches identify several apicomlexan homologs 
 
 
 
  
 
 
EuPathDB NCBI ToxoDB
ID Organism blastp blastp blastp Annotation
TGGT1_000660 Toxoplasma gondii -197 0 -198 IMC15
NCLIV_007240 Neospora caninum -130 -162 -133 hypothetical
BBOV_I004150 Babesia bovis -47 -42 -29 membrane skeletal protein
TA14770 Theileria annulata -43 -33 -29 hypothetical
TP02_0724 Theileria parva -43 -32 -21 hypothetical
PVX_083475 Plasmodium vivax -42 -48 -29 hypothetical
PKH_120230 Plasmodium knowlesi -41 -52 -30 conserved, unknown function
MAL13P1.260 Plasmodium falciparum -41 -49 -21 alveolin
PCHAS_136900 Plasmodium chabaudi -41 -43 -20 conserved, unknown function
PY03838 Plasmodium yoelii -40 -52 -23 Erythrocyte membrane protein
PBANKA_136440 Plasmodium berghei -40 -23 conserved, unknown function
NCLIV_031780 Neospora caninum -26 hypothetical
ETH_00024620 Eimeria tenella -26 erythrocyte membrane protein PFEMP3
PY00506 Plasmodium yoelii -21 hypothetical
PKH_083620 Plasmodium knowlesi -20 membrane skeletal protein
PFC0180c Plasmodium falciparum -20 Inner membrane complex protein 1a
PCHAS_040350 Plasmodium chabaudi -20 Inner membrane complex protein 1a
PBANKA_040260 Plasmodium berghei -20 Inner membrane complex protein 1a
PVX_119325 Plasmodium vivax -20 membrane skeletal protein
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Figure 3.1. The termini of IMC15 homologs are not conserved 
 
The alignment of the ten strongest BLASTp results shows very little homology in the N- 
and C-termini to IMC15. The conserved alveolin domain is shaded green. Amino acid 
colors that indicate a consensus in a column as well as chemical properties are: green 
(>50%; hydroxyl/amine/basic/glutamine), blue (>60%; hydrophobic), cyan (>50%; 
histidine/tyrosine), magenta (>50%; acidic), and red (>60%; lysine/arginine). Other 
colors are orange (glycine), yellow (proline), and pink (cysteine). Red arrows indicate 
predicted IMC15 palmitoylation sites (C4, C92, C93, C673, and C674). Blue arrows 
indicated potential phosphorylation sites that are conserved between IMC15 and 
Plasmodium (S254, T419, S545, and S547) or between IMC15, Neospora, Babesia, and 
Theileria (T352 and S386).  
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Figure 3.1. The termini of IMC15 homologs are not conserved 
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Figure 3.2. The conserved IMC15 alveolin domain contains potential 
phosphorylation sites 
 
(A) The IMC15 alveolin domain aligned with the top 10 strongest BLASTp hits 
(enlargement of the green shaded region in Fig. 3.1). Colors the same as above. Blue 
arrows indicate conserved potential phosphorylation sites between IMC15 and 
Plasmodium (S254, T419, S545, and S547) or between IMC15, Neospora, Babesia, and 
Theileria (T352 and S386). (C) Phylogenic tree of IMC15 conservation across 
apicomplexans. Phylogeny based on full-length sequences with 1000x bootstrapping. 
Values shown at nodes.   
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Figure 3.2. The conserved IMC15 alveolin domain contains potential 
phosphorylation sites 
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Figure 3.3. Homologous recombination strategies for IMC15 
 
(A) Single HR strategy for endogenous cloning of IMC15-myc3. 3’HR is sequence 
homologous to the 3’ end of IMC15 (before and not including the stop codon) and 3’dhfr 
is the dhfr-ts 3’UTR. A single black hash mark indicates linearization of the plasmid for 
transfection. Single crossover results in tagging of the 3’ end of IMC15. (B) Double HR 
strategy for direct IMC15 KO. 5’HR is sequence homologous to a genomic region 
upstream of the promoter and 3’HR is sequence downstream of the stop codon. Double 
crossover results in KO of the IMC15 locus and KI of DHFR. (C) Double HR strategy for 
replacement of the UPRT locus with a DDmyc tagged IMC15 construct. Similar strategy 
as in (B). Double crossover results in KO of the UPRT locus and KI of the tagged 
construct. (D) Double HR strategy for promoter replacement. pT7SX is seven tet operator 
repeats followed by a minimal promoter (psag1 or psag4). 5’HR is sequence homologous 
to a genomic region upstream of the promoter and the 3’HR is from the start codon into 
IMC15. Double crossover results in KO of the IMC15 promoter and KI of DHFR-TS and 
the tet-regulated promoter.  
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Figure 3.3. Homologous recombination strategies for IMC15 
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Figure 3.4. IMC15 is part of the IMC meshwork 
 
Western blots of detergent extractions using resuspension buffer (RB), 1% Triton X-100 
(TX-100), 1% deoxycholic acid (DOC), and 1% sodium dodecyl sulfate (SDS). Lanes are 
labeled “P” for pellet fraction and “S” for soluble fraction. The anti-myc blot was striped 
and re-probed with anti-IMC1 and anti-GRA1.  
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Figure 3.4. IMC15 is part of the IMC meshwork 
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Figure 3.5. IMC15 remains in the centrosomes when regulated under the DD system 
 
(A-C) Conditional KD parasites expressing pimc15 driven DDmyc-IMC15 stabilized 
with Shld1 and stained with anti-IMC15 (red) and anti-hCentrin (green) (A-B) or anti-
IMC3 (green) (C). IMC15 colocalizes with the centrosomes (A) and then expands into 
the early (B) and mid-buds (C). (D-F) The same parasite strain stained with the same 
antibodies without Shld1 shows colocalization at the centrosomes with TgCentrin1 (D), 
but then DDmyc-IMC15 fails to expand into the early buds (E) or the mid-buds (F) and 
instead remains in the centrosomes.  
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Figure 3.5. IMC15 remains in the centrosomes when regulated under the DD system 
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Figure 3.6. Parasites survive under tet mediated repression of IMC15 transcription 
(A) Plaque assays of two different representative clones, numbers 23 and 27, of IMC15 
driven by pT7S4. The left panel of each pair was cultured for seven days without ATc 
and the right panel of each pair was cultured for seven days with ATc. (B) Graph 
comparing the average plaque size of TATi Δku80 parasites, MORN1 KO parasites that 
do not form plaques with ATc (10), and three different clones of IMC15 driven by pT7S1 
cultured for seven days without ATc (blue) and with ATc (red). 
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Figure 3.6. Parasites survive under tet mediated repression of IMC15 transcription 
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Figure 3.7. IMC15 mutants suggest complex palmitoylation scheme 
On the left are the palmitoylation mutations followed by if the N-terminal YFP fusion of 
each resultant mutant produces a stable parasite line after transfection. On the right are 
diagrams of the mutants. The N- and C-termini are in green flanking the yellow alveolin 
domains. Predicted palmitoylation sites are marked with a blue asterisk and a red “X” 
indicates a mutated site.  
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Figure 3.7. IMC15 mutants suggest complex palmitoylation scheme 
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Chapter 4. Coordinated dynamics of budding in Toxoplasma gondii
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4.1. Introduction 
The visualization of cytoskeletal components in Toxoplasma by fluorescence microscopy 
has revealed daughter budding to be a highly coordinated phenomenon. The process of 
budding can be generalized by observation into four stages of cytoskeletal dynamics: 
initiation, early bud assembly, mid-budding, and late stage budding. During the initiation 
of budding and early bud assembly the foundations are laid for each layer of the 
cytoskeleton and the conoid. This seemingly chaotic stage is followed by elongation of 
the cytoskeleton to the midpoint of budding, at which time the components of the basal 
complex join MORN1 on the leading edge of the developing parasites. After the 
midpoint, the daughters begin to contract and move into the late stages of budding. The 
late stages of budding are indicated by the assembly of the glideosome and the 
incorporation of the mother’s plasma membrane onto the daughters. The timing of 
incorporation of cytoskeletal elements into the daughter buds has been determined 
individually based on comparisons to developmental markers such as MORN1 for early 
bud formation (60, 61), GAP45 for late stage budding (44), and IMC1 for everything in 
between (19, 67). This method allows for subjectivity in the timing determinations as 
different authors using different markers have different definitions of budding stages. 
This is especially true for early budding when a large number of proteins are converging 
on a small subcellular area in a short amount of time (about 30 minutes) (25).  
 In this chapter a comprehensive timeline for cytoskeletal development is 
described based on co-IFAs with established cytoskeletal components. This timeline 
provides a clear framework for evaluating the timing of incorporation of future 
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cytoskeletal factors. Furthermore, these data used in conjunction with KO phenotypes 
will provide insight into potential protein relationships and mechanisms during the 
budding process.  
 
4.2. Results 
4.2.1. Initiation of budding 
After division of the Golgi, at a DNA content of about 1.2N, the centrosome duplicates 
(19, 24, 25). The activity of the centrosomes can be monitored using the three identified 
centrin proteins in Toxoplasma, TgCentrin1, 2, and 3 (27, 72). At the point of centrosome 
duplication IMC15 and Rab11B colocalize apical to the centrosomes (Fig. 4.1A and B 
and Fig. 2.13D, E, F, and I). IMC15 is the earliest member of the IMC meshwork to 
appear in the initial bud. Rab11B is a small GTPase that is believed to traffic the vesicles 
of the alveoli to the budding daughters (13). It is reasonable that the two structures of the 
IMC, the protein meshwork and the membranous alveoli, would develop in tandem. In 
addition to Rab11B, the actin-like protein 1 (ALP1) may assist in the development of the 
IMC membranes. Previous work showed that ALP1 appears at the bud before other 
members of the IMC family, such as IMC1, but the exact timing in relation to Rab11B 
and IMC15 remains to be determined (129). MORN1 enters the daughter buds after 
Rab11B and IMC15 (Fig. 4.1C and Fig. 2.13F). 
The MT structures of the cytoskeleton begin to form at this initial budding stage 
as well. The subpellicular MT and the unusual α-tubulin-only MT of the conoid both 
begin to assemble with the duplication of the centrosome (13, 27). The MT binding 
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protein that associates with the two intraconoid MT, TgICMAP1, appears with the two 
centrosomes as well (62); however, its exact timing has yet to be determined.  
 
4.2.2. Early budding 
Following MORN1, the next components to enter the new buds are the IMC-associated  
ISP proteins. ISP3 enters first, appearing after the spindle pole has divided and the 
MORN1 rings have begun forming (Fig. 4.2A and B). ISP1 and ISP2 closely follow ISP3 
(Fig. 4.2C-F). It is difficult to determine if ISP1 precedes ISP2 slightly or if they enter the 
bud concurrently (Fig. 4.3). About 30 minutes after centrosome duplication, at a DNA 
content of about 1.8N, IMC3 and IMC1 follow the ISP proteins into the daughters (19, 
25). Often there are a faint accumulations of IMC3 near early ISP1, but IMC3 does not 
begin to form recognizable buds until the intensity of the ISP1 signal increases (Fig. 4.4). 
It is currently assumed that the other IMC proteins that localize cortically in budding 
parasites, IMC4, 6, and 10, enter the daughters with the same timing as IMC1 and 3, but 
this has not been rigorously tested. The basal complex IMCs, IMC5, 8, 9, and 13, join the 
early bud as well, but it is unclear if they do so concurrently with IMC3 or slightly later 
(Fig. 2.11 and Fig. 2.12). The components of the glideosome begin to appear during this 
early stage of budding as well. GAP50 and GAP40 are the earliest glideosome elements 
(44, 65) but their time of arrival to the daughters compared to the ISP or IMC proteins 
has yet to be determined.  
 With all of the earliest components in place, the forming daughter cytoskeletons 
begin to elongate. A ring of MORN1 marks the growing posterior end of the cytoskeleton 
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and the early conoid indicates the apical end (27, 61). Once the advancing cytoskeleton 
reaches the edge of the forming apical cap, the annuli of TgCentrin2 form (27, 60) and as 
the cytoskeleton continues past the cap region toward the budding midpoint, ISP1 
remains behind (14) (Fig. 1.3).  
Based on fluorescence recovery after photobleaching (FRAP) experiments IMC1 
is generated de novo in the growing daughters and not recycled from the mother parasite 
(19). On the other hand, FRAP experiments with IMC4 suggest some of the protein may 
be salvaged from the mother (27). These results support the idea that multiple and 
complex mechanisms operate even within the same family of proteins to cultivate the 
daughter buds.  
 
4.2.3. Mid- to late budding 
About 1.5 hr after centrosome duplication, TgCAM1, TgCAM2, and TgDLC localize to 
the MT region of the conoid (25, 27). This corresponds to about the midpoint of budding 
based on comparison of TgCAM1 and IMC3 (Fig. 4.5B). The midpoint of budding 
coincides with redistribution of the posterior IMC proteins, IMC5, 8, 9, and 13, from the 
periphery of the daughter buds to the growing ends where MORN1 is located (96) (Fig. 
2.12). This transition marks the widest part of the future mature daughters. Past this point 
the buds begin to contract as they elongate. Soon after they begin to contract heat shock 
protein 20 (Hsp20), whose function is unknown, localizes in a discontinuous striped 
pattern to the outer membrane of the IMC (130). In addition, PhIL1 localizes to the apical 
cap in these later stages of daughter development (63). 
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 During basal complex contraction, karyokinesis is completed and RNG1 appears 
at the apical polar ring (15). With the completion of contraction, the mature basal 
complex is formed. The mother cytoskeleton then begins to break down and the plasma 
membrane of the mother is incorporated into the pellicles of the new daughters in a 
Rab11A-dependent process (12, 17). The glideosome assembles between the forming 
plasma membrane and the IMC as GAP45 is recruited to GAP50 bringing along MLC1 
and MyoA (44, 65). Overexpression of a dominant negative Rab11A construct reveals 
that this transport protein is required for proper completion of the glideosome as well 
(12). 
 
4.2.4. Mature parasites in G1 
The emergent daughter parasites are now fully mature and the mother parasite has been 
left behind as a residual body. For unknown reasons that are the subject of much 
speculation in Chapter 2, three more IMC proteins are incorporated into the cytoskeleton 
during G1: IMC7 and 12 in the first third of G1 and IMC14 at about the midway point of 
G1 (96) (Fig. 2.9 and 2.10). Throughout G1 IMC1 is continually added to the mature 
cytoskeleton but at a slower rate than during budding (19). It is unknown if there is active 
turnover and replacement of the other cytoskeletal proteins after budding is complete. It 
is reasonable to speculate that this is true for proteins like IMC1 and IMC4 that maintain 
their level of intensity in IFA between daughter development and G1 phase (Fig. 2.4-6). 
Proteins like IMC3, 6, and 10 that exhibit significantly weakened signals during G1 are 
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probably less dynamic during G1, being degraded but not being replaced (96) (Fig. 2.5 
and 2.8). 
 
4.3. Discussion  
Internal daughter budding in Toxoplasma has four main stages: initiation, early bud 
formation, mid-budding, and late stage budding. Based on comparative IFAs performed 
for this project, I was able to develop a timeline of early through mid-budding activity. 
Two of the first indicators of budding are IMC15 and Rab11B representing the 
beginnings of the IMC meshwork and the IMC alveoli, respectively (13) (Fig. 4.1A and 
B and Fig. 4.6 panel 1). MORN1, a basal complex component, organizes into small rings 
at the nascent buds immediately following the organization of these earliest cytoskeletal 
components (27, 60, 61) (Fig. 4.1C, Fig. 4.2B, and Fig. 4.6 panel 2). MORN1 is followed 
by ISP3, ISP1, and ISP2 (Fig. 4.2, Fig. 4.3, and Fig. 4.6 panels 3-5). The cortical IMC 
proteins of the buds enter the daughters next either concurrent with or immediately 
preceding the basal IMCs (Fig. 4.4 and Fig. 4.6 panel 6). At about the midpoint of 
budding the TgCAM1 of the conoid is added to the daughters (27, 63)(Fig. 4.5 and Fig. 
4.6 panel 7). At the midpoint the basal IMC proteins redistribute to the leading edge of 
the bud to join MORN1 (Fig. 4.6 panel 7).  
 It is important to note, especially with the early bud formation findings, that the 
observed dynamics reported here are all based on comparative IFAs. With the earliest 
stages the differences in timing are probably only minutes long since this stage lasts 
around 30 minutes. With such short temporal differences, variations in expression levels 
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become more important and could amplify differences in detection limits, skewing the 
results. A protein that has a low expression level may be localizing to the bud as early as 
IMC15 but its detection may be delayed. Furthermore, some of the constructs presented 
here are driven by overexpression promoters that could alter their expression timing. 
Those proteins visualized with epitope or fluorescence tags could have delayed entrance 
to their proper sub-compartment contributable to hindrance from the tag. Moreover, they 
may experience altered residence times due to the tag. Despite these issues all of the 
reported results coincide with currently available literature and the resulting timeline 
fulfills the goal of developing a framework for defining the specific steps of daughter 
budding.  
 The earliest stages of daughter budding are highly coordinated with the addition 
of proteins clearly staggered throughout a short period of time. These differences in 
timing suggest that complex mechanisms and relationships are involved in daughter bud 
initiation. The addition of PhIL1, several conoid components, and RNG1 to specific 
compartments of the daughters during the middle to late stages of budding shows that the 
daughters are not simply built from the top down, but instead it is in an iterative process 
that must involve several coordinated signals. Furthermore RNG1, which forms in the 
latest stages of budding, will continue forming rings even if bud formation and nuclear 
division is blocked with oryzalin (15). This presents the possibility of budding controls 
that are not associated with bud formation or a lack of checkpoints once mitosis is 
initiated. In addition, the trigger for relocalization of the posterior IMCs at the midway 
point of budding remains unknown.  
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 Though the comprehensive timeline of daughter bud organization and 
development presented here does not provide mechanistic information, it does clearly 
define the steps of bud development. These definitions will eliminate much of the 
subjectivity currently involved in classifying components of the cytoskeleton as early, 
middle, and late elements and allow for more direct comparisons of timing amongst 
proteins. This model of developmental dynamics can be used in conjunction with future 
cytoskeletal KOs to identify and further define relationships and mechanisms involved in 
internal daughter budding.  
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Figure 4.1. IMC15 and Rab11B precede MORN1 into the initial daughter bud 
 
(A-B) Parasites expressing YFP-IMC15 (green) and DDmyc-Rab11B (red) in the 
presence of Shld1 colocalize at the centrosomes (A) and then expand into the forming 
daughter buds (B). (C) DDmycRab11B (red) co-stained with anti-MORN1 (green). 
Arrow indicates an unduplicated spindle pole. Both constructs are driven by the ptub 
promoter. 
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Figure 4.1. IMC15 and Rab11B precede MORN1 into the initial daughter bud 
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Figure 4.2. ISP3 precedes the related ISP1 and ISP2 into the forming daughter buds 
(A-B) Parasites expressing ISP3-YFP (green) are co-stained with anti-MORN1 (red) 
showing no ISP3 at the recently divided spindle poles (A) and then colocalization of ISP3 
with the early MORN1 rings (B). ISP3-YFP parasites present with numerous inclusion 
bodies; therefore, the arrows indicate the bud-associated ISP3. (C-D) ISP3-YFP parasites 
(green) co-stained with anti-ISP1 show clear rings of ISP3 without ISP1 (C) and then 
slightly later stage parasites with early expression of ISP1 (D). (E-F) Parasites expressing 
ISP3-YFP (green) and ISP2-HA (red) show no ISP2 at an early budding stage (E) and 
then colocalization with ISP3 (F). ISP3-YFP is driven by the ptub promoter and ISP2-HA 
is under the control of its native promoter.  
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Figure 4.2. ISP3 precedes the related ISP1 and ISP2 into the forming daughter buds 
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Figure 4.3. ISP1 and ISP2 may associate with the early bud concurrently 
Parasites expressing ISP2-HA (red) are co-stained with anti-ISP1 (green). Arrows 
indicate faint ISP2 buds that colocalize with the more intense ISP1. ISP2-HA is under the 
control of its native promoter.  
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Figure 4.3. ISP1 and ISP2 may associate with the early bud concurrently 
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Figure 4.4. ISP1 associates with the daughter buds slightly before IMC3  
(A-B) Wild-type parasites co-stained with ISP1 and IMC3. Arrows in (A) indicate 
amorphous accumulations of IMC3 near the buds as indicated by ISP1. The IMC3 does 
not fully associate with the buds until after ISP1, but both proteins are clearly established 
in the daughters at an early stage (B).  
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Figure 4.4. ISP1 associates with the daughter buds slightly before IMC3  
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Figure 4.5. TgCAM1 enters the conoid near the midpoint of budding 
(A-B) Parasites expressing TgCAM1-YFP (green) co-stained with anti-IMC3 show an 
absence of TgCAM1 in the early bud (A). TgCAM1 enters the conoid around the 
midpoint of budding as indicated by the arrows (B). TgCAM1-YFP is driven by the ptub 
promoter.  
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Figure 4.5. TgCAM1 enters the conoid near the midpoint of budding 
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Figure 4.6. Timeline of early budding activity 
Panel 1 is the initiation stage of budding, panels 2 through 6 are the early stages, and 
panel 7 represents the midpoint of budding. Bud components correspond to the text 
colors below the panels. Included components are those whose timing has been verified 
by comparative IFA as part of this project.  
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Figure 4.6. Timeline of early budding activity 
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Chapter 5. Conclusions and Future directions 
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5.1. Conclusions 
Toxoplasma replicates rapidly, destroying infected cells, and causing the tissue lesions 
that are responsible for the escalation of toxoplasmosis. Replication occurs by an internal 
budding mechanism that begins with the division of the Golgi and the duplication of the 
centrosome (17, 23-25, 29). Progression of budding requires the proper development of 
the cytoskeleton (10-16); therefore, the components of this structure are attractive 
potential therapeutic targets and comprise a growing area of research.  
In this thesis, a new family of cytoskeletal proteins was identified. The spatial and 
temporal model of cytoskeletal development that evolved from documenting the 
subcellular localization dynamics of all 14 members of the Toxoplasma alveolin motif-
containing intermediate filament-like protein family provided unprecedented detail into 
the process of IMC biogenesis and exposed phenomena not previously observed. The 
diverse behaviors of these related genes are controlled at three levels: expression profile, 
primary protein sequence, and post-translational modifications. The localization of IMC7, 
12, and 14 to the cortical IMC during G1 is strongly correlated to their expression 
patterns (Fig. 2.4) with IMC14 expression peaking in the first third of G1 and IMC7 and 
12 toward the middle of G1. The importance of the primary protein sequence is 
illustrated by the ability of the IMC3 and IMC8 alveolin domains to localize properly 
when expressed alone. The impact of post-translational modifications is expressed in the 
proteolytic cleavage of IMC1 (67) and the potential dominant negative effects of IMC15 
predicted palmitoylation site mutants.  
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The intriguing localization of IMC7, 12, and 14 to the independent, seemingly 
fully formed cytoskeleton during G1 could serve to distinguish the mother parasite that 
must be degraded prior to cytokinesis from the internally budding daughters as discussed 
in Section 2.3. Furthermore, IMC7, 12, and 14 may serve another function since they 
mostly relocate back to the cytoplasm after egress from the host cell (Tomasz Szatanek, 
Brooke Anderson-White, Michael White, Jeroen Saeij, and Marc-Jan Gubbels; paper 
under review). These Toxoplasma-specific proteins could be tied to the relocation of the 
glycolytic enzymes (88), part of a signaling cascade, and/or involved in cytoskeletal 
stabilization and flexibility for egress and invasion.  
IMC5, 8, 9, and 13 localize to the early buds and then at the midpoint of budding 
they shift to basal end of the growing parasite with TgCentrin2 and the daughters begin to 
constrict (Fig. 2.12). The trigger for this basal migration is unknown as is the role of 
these basal IMCs in constriction. Involvement in a septin-related mechanism is unlikely 
based on the minimal role of actin in daughter budding (40), the highly divergent nature 
of Toxoplasma myosins (42, 43), and the often incomplete abscission of the daughters 
(95). However, it is possible that these IMCs function in a divergent yet analogous 
mechanism in Toxoplasma. 
Once the parasite is mature, these IMCs and TgCentrin2 along with IMC15 and 
MORN1 form a three-ringed structure at the posterior end of the parasite. These regions 
could coincide with the BIR and BIC revealed by EM (Fig. 2.12H-J and 2.15B). The BIC 
may bend over the alveoli to provide the only visible connection between the IMC and 
the plasma membrane, but this requires closer examination to verify. In addition to a role 
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in constriction, the members of this basal complex could be involved in maintenance of 
cytoskeleton integrity at the posterior end of the parasite during the mechanical stresses 
of invasion. A similar basal complex has only been described in E. tenella merozoites 
(33) and, like IMC7, 12, and 14; IMC5, 8, 9, and 13 are unique to Toxoplasma.  
 IMC15 is the earliest cytoskeletal indicator of daughter bud formation as it 
colocalizes with the duplicated centrosomes. From the centrosomes, IMC15 expands into 
the daughter buds (Fig. 2.13D and G) and remains cortical in the mature IMC (Fig. 
2.13A-G). However, the amount of IMC15 that remains in the mature parasite is beyond 
the detection limit of the IMC15 antibody (Fig. 2.13H and I) so its presence was verified 
through detergent extractions (Fig. 3.4).  
 Unlike IMC7, 12, and 14 and the IMCs of the basal complex, IMC15 is conserved 
across the Apicomplexa despite the variations in division modes within this phylum.  
Though the primary role of IMC15 may be earlier in division, MORN1 is an essential 
protein involved in the development of the Toxoplasma cytoskeleton that is conserved 
throughout apicomplexan species and between endodyogeny, endopolygeny, and 
schizogony (95). Our inability to KO IMC15 suggests that it is essential as well as 
conserved like MORN1. To delve into the specific function of IMC15 three conditional 
KD strains were created using the DD-system, the T7S4 repressible promoter, and the 
T7S1 repressible promoter. None of the strains could sufficiently downregulate IMC15 to 
a KO-like background level, proving that extremely low levels of IMC15 expression are 
sufficient for parasite viability. Furthermore, use of the DD-system exposed a high 
affinity of IMC15 for the centrosomes. The basis for this affinity is yet to be determined.  
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 Post-translational modification could factor into the behavior of IMC15. Based on 
the detergent extractions it does not appear that IMC15 undergoes a cleavage event 
similar to IMC1 (67), but further experiments would be necessary to verify the absence of 
such an event. Post-translational modifications could influence the localization of IMC15 
since primary protein sequence alone is not sufficient as it is in IMC3. IMC15 has five 
sites strongly predicted to be palmitoylated. The three sites in the N-terminus appear to 
be redundant as no defect is observed after mutation of these sites until all three are 
mutated together. The quintuple mutant has no observable phenotype and, therefore, may 
create an inert-like protein that interacts with the native IMC15 and is carried to the 
proper sub-compartments. However, three mutant constructs (C673A/C674A, 
C4A.C92A/C93A, and C4A.C673A/C674A) could potentially exert toxic dominant 
negative effects on the parasite. We cannot verify at this time that this toxicity is due to 
an abrogation of palmitoylation or a secondary effect from changing the Cys amino acids 
to Ala. In addition to palmitoylation, phosphorylation state could affect the behavior of 
IMC15. We have identified six conserved potential phosphorylation sites, including a 
potential NIMA kinase site (127), that are candidates for mutation. 
 The IMC family was incorporated into the broader context of cytoskeletal genesis 
with the development of a comprehensive relative timeline of daughter budding (Chapter 
4). This timeline provides a framework for identifying the precise temporal organization 
of all current and future cytoskeletal components. It will serve as a tool to assist in the 
identification of developmental mechanisms and protein relationships especially as more 
KOs are created.   
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 The IMC proteins are active in cytoskeletal development from the duplication of 
the centrosomes through the constriction of the posterior end. The diversity of the 
subcellular dynamics of this group suggests complex interactions between the members 
of this family as well as with other cytoskeletal elements. Further elucidation of the 
functions of these proteins will increase the resolution of the timing and the mechanisms 
behind the development of the daughter buds. A greater understanding of these 
Toxoplasma-specific proteins could lead to improved therapeutics in the future.  
 
5.2. Future directions 
Based on the data presented here, the organization of the IMC proteins is varied and 
complex. In order to determine if this diversity in subcellular localization is reflected in 
their functions we will need to continue to create KOs and conditional KDs of these 
proteins. Specifically the mature-only IMCs, IMC7, 12, and 14, and the basal IMCs, 
IMC5, 8, 9, and 13, are of interest. The members of these groups are unique to 
Toxoplasma and elucidation of their functions would increase our understanding of 
Toxoplasma-specific mechanisms. The possible redundancy of the IMCs that share the 
same spatio-temporal patterns may necessitate the generation of multi-gene KOs to 
evaluate their functions.  
 For IMC7, 12, and 14 it would be interesting to test if their extracellular 
relocation to the cytoplasm is calcium and/or potassium concentration dependent. This 
would involve experiments similar to those described in Pomel et al., such as incubating 
parasites in media mimicking extracellular and intracellular potassium levels and 
 135 
monitoring protein localization (88). These experiments could be repeated with KO 
strains to fully assess the function of IMC7, 12, and 14.  
 A sufficient KO background of IMC15 remains elusive. Due to the very low level 
of IMC15 expression sufficient for parasite survival a complete KO is required. We are 
currently constructing a Cre-Lox controlled conditional KO (122-124). As a secondary 
approach for functional studies we are developing DD-controlled dominant negative 
constructs based on the deletion and palmitoylation mutants. Furthermore, we are 
conducting competition assays with the tet-repressible conditional KDs to verify that they 
do exhibit slower growth than the parental TATiΔku80 strain.   
 Once an IMC15 KO has been established the contributions of the individual 
domains (N-terminus, alveolin, and C-terminus) to IMC15 behavior can be determined. 
All previous experiments have taken place in a wild-type background where interactions 
between the constructs and the native proteins could account for the observed localization 
patterns. Emphasis should be placed on the C-terminus, which may have an important 
function. Furthermore, the contributions of post-translational modifications, specifically 
palmitoylation and phosphorylation, to IMC15 should be studied in the KO background. 
It has not been determined that changes in palmitoylation state and not a secondary 
change related to the Cys to Ala mutations are responsible for the potentially toxic effects 
of the mutants; thus palmitoylation assays will be considered. 
 The detergent solubility experiments with IMC15 did not suggest that IMC15 
undergoes a cleavage event during maturation similar to IMC1 (67); however, further 
experimentation would be necessary to prove this. Pulse-chase labeling experiments 
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would be a possibility. It is important to keep in mind that these experiments would 
require large numbers of parasites for sufficient protein detection due to the low 
expression levels of IMC15.    
 An interesting experiment that would solidify a role for IMC15 in the nucleation 
of budding would be to attempt reactivation of rapid budding in parasites that have 
differentiated from tachyzoites to slow growing pseudo-cystic bradyzoites. This could be 
accomplished in two ways: first, a DD-controlled construct could be transfected into 
Prugniuad parasites (Type II strain) and then IMC15 activated with the addition of Shld1 
after bradyzoite differentiation; or, alternatively, YFP-IMC15 driven by the tubulin 
promoter could be transfected into Prugniuad parasites to test if constitutive 
overexpression of IMC15 inhibits bradyzoite differentiation. It is important to bear in 
mind that these experiments assume IMC15 is the limiting factor in bradyzoites for 
budding initiation and not any enzymes that may modify IMC15 or any binding partners 
necessary to instigate cytoskeletal formation.  
 The conservation of IMC15 across apicomplexan species suggests that its 
function may be conserved across apicomplexan division methods. We are collaborating 
with a Sarcocystis lab to look at the role of IMC15 in endopylogeny and are establishing 
a collaboration with a Plasmodium lab to look at schizogony. There are clear homologs 
of IMC15 in Plasmodium (Fig. 3.4) and, though the Sarcocycstis genome sequencing 
efforts are in the early stages making identification of an IMC15 homolog difficult, it is 
the closest relative to Toxoplasma after Neospora (131).  
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 Nanoresolution microscopy is an underutilized tool in the Toxoplasma field that 
would greatly improve our ability to resolve the fine details of cytoskeletal development. 
Since immunoprecipition with the Toxoplasma cytoskeletal proteins is difficult due to 
solubility issues, the identification and validation of interactions is difficult. 
Nanoresolution microscopy could assist in this process and would be especially useful in 
future studies of early budding, the apical complex, and the basal complex.  
 The ultimate goal of infectious disease work is to contribute to the improvement 
of therapeutics. Drug screening is not the intent of this work, but there are drugs that 
target traditional IFs currently used to treat other diseases that could be tested for their 
efficacy in disrupting the IF-like proteins of Toxoplasma.  One such drug is withaferin A 
(WFA), which is used to treat cancer by modifying the cysteines of Type III IFs in 
tumors (132). Many of the IMC proteins are cysteine rich so we attempted to inhibit 
cytoskeletal formation by treating parasites with WFA. Unfortunately, WFA did not 
affect Toxoplasma, but identifying and testing the effects of other currently approved IF 
targeting drugs could be pursued in the future.  
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Chapter 6. Materials and Methods 
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6.1. Parasites 
RH strain parasites, Δku80 strain parasites (111), TATiΔku80 (Drs. Lilach Sheiner and 
Boris Striepen; unpublished), and transgenic derivatives of these primary strains were 
used throughout this study. Parasites were maintained in human foreskin fibroblasts 
(HFF) as previously described (116). All parasites were grown at 37°C except for the FV-
P6 temperature sensitive mutant, which was grown at 35°C (permissive) or 40°C 
(restrictive). Stable parasites expressing transgenes were selected under chloramphenicol, 
pyrimethamine, or mycophenolic acid pressure and cloned by limiting dilution.  
 
6.2. RACE 
For IMC genes 7, 9, and 12-15 we determined the 5’- and 3’-ends by RACE using the 
GeneRacer kit (Invitrogen) according to the manufacturer’s instruction. All primer 
sequences are provided in Table 4.1. 
 
6.3. Sequence analysis 
The IMC gene family was identified through reciprocal BLASTp searches of the T. 
gondii genome of the ME49 strain in ToxoDB version 5.1 using a cut-off e-value of 10-3 
(75, 133). The alveolin repeat domains of each IMC were determined by first identifying 
the VPV and EKIVEVP repeats as defined in (74) and then analyzing the protein 
sequences for novel repetitive regions with the REPRO program (76). The final 
determination of each alveolin domain’s boundaries was done manually based on the 
V/E/K/Q/R/P richness of the domain. Predictions of lipid modification (myristoylation, 
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farnesylation, geranylgeranylation, palmitoylation) were performed using the suite 
available at http://mendel.imp.ac.at/mendeljsp/index.jsp, (134, 135).  
 IMC15 homologs were identified through BLASTp searches of the apicomplexan 
sequenced genomes (Babesia, Cryptosporidium, Eimeria, Neospora, Plasmodium, 
Theileria, and Toxoplasma) in EuPathDB (97). A cut-off e-value of -20 was selected as it 
is the next lowest score compared to the e-value of the first Toxoplasma IMC protein 
result. NCBI BLASTp queries with IMC15 used the non-redundant protein sequences 
database and a cut-off e-value of -32 as determined in the same manner as for EuPathDB. 
The 10 strongest hits were reciprocally BLAST searched in ToxoDB version 7.0 (75). 
IMC15 was aligned with these best 10 hits using ClustalW version 2.1 and analyzed 
using ClustalX ver 2.1 (136, 137).  
The phylogenetic trees were generated with the MEGA program version 5.05 
(138) using a maximum likelihood model with 1000X bootstrapping. Palmitoylation sites 
were predicted (medium to high likelihood) by CSS-Palm2.0 (77). Phosphorylation sites 
were predicted by NetPhos 2.0 with T352, T419, and S545 being greater than the 
threshold of 0.5 (139).   
 
6.4. Plasmids   
All PCR primer sequences are provided in Table 6.1. Plasmids ptub-YFP-IMCx/sagCAT 
and ptub-IMCx-YFP/sagCAT are based on the ptub-YFP2(MCS)/sagCAT plasmid (140) 
with an extra multiple cloning site containing EcoRV and XmaI/SmaI introduced after the 
stop codon of the second YFP based on the ptub-cherryRFP2/sagCAT plasmid (kindly 
 141 
provided by Giel van Dooren and Boris Striepen, University of Georgia). Complete ORFs 
were amplified from cDNA generated from either Type I (RH strain) or Type II 
(Prugniaud strain; cDNA library kindly shared by Peter Bradley, UCLA) tachyzoites. 
Amplicons were BglII/AvrII cloned for C-terminal YFP fusions or AvrII/EcoRV, 
AvrII/XmaI, or NheI/XmaI for N-terminal YFP fusions. The same strategy was employed 
to generate cherryRFP fusions. 1500 bp endogenous promoters were PCR amplified from 
genomic DNA and cloned by PmeI/BglII into ptub-YFP-IMCx/sagCAT, ptub-IMCx-
YFP/sagCAT, or ptub-IMCx-cherryRFP/sagCAT. Deletion and chimeric proteins were 
cloned by PCR-fusion amplification of select domain inserts flanked with AvrII/EcoRV 
or NheI/XmaI sites (141) and cloned into ptubYFP2(MCS)/sagCAT.  
Transfection of ptub-YFP-IMC5/sagCAT did not result in a stable parasite line. 
Therefore a second conditional expression system, the DD system, was employed for 
IMC5. ptub-DD-YFP-IMC5/sagCAT was generated by PCR amplification of YFP-IMC5-
3’dhfr from ptub-YFP-IMC5/sagCAT with primers Nhe-Sph-YFP-F and 3dhfr-Not-R, 
digested with NheI and NotI and cloned into ptub-DDmycYFP-CAT [kindly provided by 
Markus Meissner, Heidelberg University; (142)] digested with AvrII and NotI. The myc 
epitope tag was removed by SphI digestion and religation. This resulted in plasmid ptub-
DD-YFP-IMC5/sagCAT.  
Plasmid ptub-myc2-centrin2/sagCAT was generated by AvrII/NotI swapping of 
the TgCentrin2-3’dhfr segment from plasmid pmin-RFP-Centrin2/sagCAT [(83); kindly 
provided by Dr. John Murray, University of Pennsylvania] into ptub-myc2-
MORN1/sagCAT (10). 
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For endogenous tagging the plasmid LIC-3’1.5kbIMC15-myc3/DHFR was created 
as previously described (111). 1.5 kb of IMC15 upstream of the stop codon (stop codon 
omitted) was amplified from genomic RH DNA using the primers IMC15-F-Ku80LIC 
and IMC15-R-Ku80LIC. The PCR product was treated with T4 polymerase and dCTP for 
20 min at 37°C, 2 µL of 0.5M EDTA was added to stop the reaction, and the PCR 
product was purified over a column. LIC-myc3/DHFR (kindly provided by Micheal 
White, University of South Florida) was digested with PacI and then treated with T4 
polymerase and dGTP. For ligation independent cloning (LIC) 2 µL of the T4 treated 
PCR product, 8 µL of the T4 treated LIC-myc3/DHFR, 2 µL of ligase buffer, and 20 µL 
of dH2O were incubated at room temperature overnight.  10 µL were then transformed 
into chemically competent DH5α cells. The plasmid was linearized within the 
homologous region with MfeI prior to transfection. 
IMC15 direct KO vectors were created using the MultiSite Gateway Pro system 
(Invitrogen). Plasmid pDONR221-5’ IMC15 R1/R4 was cloned by PCR amplifying 1,035 
bp upstream of the IMC15 promoter from genomic DNA using the primers 5’IMC15-F-
B1 and 5’IMC15-R-B4 and then cloned by BP reaction into the plasmid pDONR221 
P1/P4 (kindly provided by Jeroen Saeij, MIT). Plasmid pDONR221-3’IMC15 R3/R2 was 
cloned by PCR amplifying 1,035 bp after the IMC15 stop codon using the primers 
3’IMC15-F-B3 and 3’IMC15-R-B2 and then cloned by BP reaction into the plasmid 
pDONR221 P3/P2 (kindly provided by Jeroen Saeij, MIT). Plasmids pDONR221-5’ 
IMC15 R1/R4, pDONR221-HXGPRT R4r/R3r (kindly provided by Jeroen Saeij, MIT), 
and pDONR221-3’IMC15 R3/R2 were combined with the destination vector pTgKO2 
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(kindly provided by Jeroen Saeij, MIT) to create the plasmid pTgKO2-IMC15-HXGPRT 
by LR reaction. Plasmids were linearized with MfeI prior to transfection. 
 Constructs were targeted to the UPRT locus using the plasmid 5’UPRT-YFP-
3’UPRT. First the ptub-YFP2(MCS)/sagCAT plasmid was modified by destruction of the 
NotI site through digestion, T4 polymerase overhang removal, and religation and then the 
psagCATsag cassette was removed through XhoI digestion and religation. The 1,000 bp 
5’ UPRT sequence is 166 bp upstream of the 5’UTR and was amplified using the primers 
5UPRT-F-XhoI and 5UPRT-R-BglII. The reverse primer also contains AgeI and PmeI 
sites to create a new multiple cloning site. The 3’ region is 1,000 bp that begins 
immediately after the 3’UTR of UPRT and was amplified using the primers 3UPRT-F-
AvrII and 3UPRT-R-BamHI. The forward primer also contains NotI and HpaI sites to 
create a new multiple cloning site. The 5’ and 3’ regions were cloned into the modified 
ptub-YFP2(MCS)/sagCAT plasmid with XhoI/BglII and AvrII/BamHI respectively.  
 The DD-tagged conditional KD IMC15 construct was created by amplifying 
IMC15-3’dhfr from ptub-YFP-IMC15/sagCAT with IMC15-F-NheI and 3dhfr-R-NotI and 
then cloning into ptub-DDmycYFP/CAT digested with AvrII and NotI. The promoter was 
added through PmeI/BglII swapping with pimc15-YFP-IMC15/sagCAT to create the 
pimc15-DDmyc-IMC15/sagCAT plasmid. 5’UPRT-pimc15-DDmyc-IMC15-3’dhfr-
3’UPRT was created by PmeI/NotI cloning. ApaI was used to linearize the plasmid for 
transfection.   
 The pT7S4 promoter KO plasmid was cloned by amplifying a 5’ 1 kb region 
immediately upstream of the promoter with the primers 5’IMC15-F-AseI and 5’IMC15-
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R-AseI; digesting it with AseI; and ligating into the plasmid p2NdeI_DHFR_T7S4_myc3 
(kindly provided by Lilach Sheiner and Boris Striepen; University of Georgia) digested 
with NdeI. The 2 kb 3’ region starting with the IMC15 start codon was amplified with the 
primers IMC15-F-Bgl and IMC15int-R-NheI and then cloned by BglII/AvrII or NheI 
digest into the 5’ sequence containing plasmid to create Tet7Sag4-pimc15 KO-DHFR. 
The plasmid was linearlized with NotI before transfection.  
 The plasmid Tet7Sag1-pimc15 KO-DHFR was created by digesting pTetOSag1-
A-NLS-CRE-myc-DHFR (Marc-Jan Gubbels; unpublished) with NotI, blunting the end 
with T4 polymerase, and then digesting with BclII, and then ligating the promoter into 
p2NdeI_DHFR_T7S4_myc3 using a third irrelevant enzyme site (TIES) with ScaI, SpeI, 
and BglII to avoid an internal SpeI site (143). The plasmid was linearlized with ScaI 
before transfection.  
 Palmitoylation and phosphorylation mutants were generated using QuickChange 
Site-Directed Mutagenesis (Stratagene). Mutated sequences were amplified from pSC-A-
IMC15 (Stratacloned plasmid; Stratagene) and sequenced with the T7 and T3 primers 
(MWG Operon). Triple, quadruple, and quintuple mutants were created through multiple 
rounds of PCR with different primers. Mutant sequences were cloned by NheI/XmaI 
swapping into AvrII/XmaI digested ptubYFP2(MCS)/sagCAT. Mutant C4A was cloned by 
amplifying IMC15 with the primers IMC15.C4A-F-NheI and IMC15-R-XmaI , digesting 
with NheI and XmaI, and ligating into AvrII/XmaI digested ptubYFP2(MCS)/sagCAT. 
 Plasmid ptub8-DD.myc.Rab11B_WT_HX was kindly provided by Dr. Markus 
Meissner (University of Glasgow). The ISP plasmids: pisp1-ISP1-YFP/HXGPRT, pisp2-
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ISP2-HA/HXGPRT, and ptub-ISP3-YFP/HXGPRT were kindly provided by Dr. Peter 
Bradley and Josh Beck (UCLA). 
 
6.5. PCR verification of homologous recombinations 
 
All verification PCR primer sequences are provided in Table 6.1. Endogenous tagging of 
IMC15 was verified with the primer pairs IMC15-CF/IMC15-R-XmaI and myc-F1/3dhfr-
Not-R. Replacement of the entire IMC15 locus with HXGPRT was verified with the 
primer pairs 5’IMC15ver-F/HX-ver-R and HX-ver-F/3’IMC15ver-R. Reinsertion of 
genomic IMC15 was identified with the primer pair IMC15-NheI-F and IMC15int-ver-R. 
Proper UPRT vector insertion was verified with the primer pairs 5’UPRT-F-ver/UPRT-R-
ver and 3’UPRT-R-ver/UPRT-F-ver. Proper insertion of Tet7Sag4-pimc15KO-DHFR and 
no reinsertion of pimc15 were verified with the primer pairs 5’IMC15ver-
F/5’DHFRCXR, T7Sag4-F-PmeI/IMC15int-ver-R (alveolin), pimc15-F-PmeI/pimc15-R-
BglII, and pimc15-ver-F/IMC15int-ver-R (alveolin). Proper insertion of Tet7Sag1-
pimc15KO-DHFR and no reinsertion of pimc15 were verified with the primer pairs 
5’IMC15ver-F/5’DHFRCXR, Tet7ver-F/IMC15int-ver-R (alveolin), pimc15-F-
PmeI/pimc15-R-BglII, and pimc15-ver-F/IMC15int-ver-R (alveolin). 
 
6.6. Generation of antisera 
The full length ORF of IMC11 and the 5’-end before the alveolin repeats from IMC3 (1-
120 aa), IMC5 (1-350 aa), and IMC15 (1-350 aa) were amplified from cDNA and cloned 
into plasmid AVA0421 (144) to generate a His6 N-terminal fusion. Fusion proteins were 
expressed in BL21 Star (DE3) pLysS E. coli (Invitrogen) and purified over TALON 
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Resin (Clontech). Polyclonal antisera were generated by rat immunizations (Covance). 
Antibodies were affinity purified against corresponding recombinant protein cross-linked 
to cyanogen bromide Sepharose 4B (Sigma) (145). 
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6.7. Immunofluorescence assays 
 IFAs were performed as described (82). The following primary antibodies were used: 
MAb 45:36 IMC1 (kindly provided by Gary Ward, Univ. Vermont), rat anti-IMC3, rabbit 
anti-IMC3 (68), rat anti-IMC5, rat anti-IMC15, rabbit anti-MORN1 (82), rabbit anti-
human centrin (kindly provided by Iain Cheeseman, Whitehead Institute), rabbit anti-
cherryRFP (kindly provided by Iain Cheeseman, Whitehead Institute), rabbit anti-GAP45 
(44), rabbit anti-TgCentrin1, mouse anti-ISP1 (kindly provided by Peter Bradley and Josh 
Beck, UCLA) and rabbit anti-FKBP12N12 (Thermo Scientific). Secondary antibodies 
conjugated to Alexa350, 488 or 594 were used (Invitrogen). Nuclear material was co-
stained with 4',6-diamidino-2-phenylindole (DAPI). 
 
6.8. Fluorescence microscopy 
A Zeiss Axiovert 200M wide-field fluorescence microscope equipped with a α-Plan-
Fluar 100x/1.45 NA oil objective, and a Hamamatsu C4742-95 CCD camera was used. In 
addition, a Leica TCS SP5 inverted confocal microscope with a 100x/1.4 NA oil 
objective was used. Time-lapse microscopy was performed on the Zeiss microscope. 
Images were analyzed and processed using Openlab and Volocity (Improvision).  
 
6.9. Electron microscopy 
Intracellular parasites were fixed in 4% glutaraldehyde in 0.1 M phosphate buffer pH 7.4 
and processed for routine electron microscopy (146). In summary, cells were post-fixed 
in OsO4 and treated with uranyl acetate prior to dehydration in ethanol, treatment with 
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propylene oxide, and embedding in Spurr’s epoxy resin. Thin sections were stained with 
uranyl acetate and lead citrate and examined with a JEOL 1200EX electron microscope. 
 
6.10. Detergent extractions 
Parasites were allowed to be extracellular for 24 hr before they were filtered and 
resuspended in resuspension buffer (50 mM Tris pH 8.0 and 150 mM NaCl) to a 
concentration of 4x106 parasites/µL. Triton-X100, DOC, and SDS were added to 
individual aliquots at a concentration of 1%. A protease inhibitor cocktail (Sigma) was 
added in a 1:100 ratio. SDS extraction was performed for 10 min at 98°C and then the 
samples were spun at room temperature for 20 min at 13,000 rpm. All other extractions 
were performed on ice for 45 min and then spun at 4°C for 20 min at 13,000 rpm. 
Supernatants were removed as the soluble fraction and the pellets were resuspended in a 
volume of resuspension buffer equivalent to the supernatant.  
 
6.11. Western blots 
Western blots were performed as previously described (82). For the anti-GFP blots, lysate 
equivalent to 20x106 to 40x106 parasites was loaded on a 12% NuPAGE Bis-Tris gel 
(Invitrogen). Proteins were transferred to PVDF membrane (Bio-Rad) and then blocked 
overnight in 5% ImmunoPure Normal Goat Serum (Thermo Scientific). YFP fusion 
proteins were detected with mouse anti-GFP (1:1,000 or 1:2,000; Abgent) in 5% goat 
serum and then washed 3 times for 10 min each with TBS containing 0.1% Tween 
(TBST). Subsequently the membrane was incubated with horse radish peroxidase (HRP) 
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conjugated anti-mouse antibody (1:10,000; DakoCytomation), washed again with TBST, 
and finally washed for 5 min with TBS alone. Signals were visualized using Immobilon 
chemiluminescent HRP substrate (Millipore) and captured on a Syngene G:BOX 
ChemiHR16 running GeneSnap software (v7.07) for 2 to 20 min.  
 For the detergent extraction blots, lysate equivalent to 80x106 parasites was 
loaded and 5% milk was used to block. Endogenous IMC15-myc3 was detected with 
mouse anti-c-myc(9E10)-horseradish peroxidase (HRP) conjugated (1:2000, Santa Cruz 
Biotech), IMC1 was detected with mouse anti-IMC1 (1:2000, Gary Ward, University of 
Vermont), and GRA1 was detected with mouse anti-GRA1 [1:15,000 of stock, Marie-
France Cesbron-Delauw, Institut Pasteur de Lille, (147)]. For IMC1 and GRA1 the blot 
was incubated with HRP conjugated anti-mouse antibody (1:10,000; DakoCytomation). 
All dilutions were in 5% milk. Signal visualization on the Syngene G:BOX was 80 min 
for anti-c-myc and 2 min for anti-IMC1 and anti-GRA1 . The blot was stripped between 
labelings by washing with 1X PBS for 10 min at room temperature, then incubating with 
stripping buffer (62.5 mM Tris-HCl pH 6.7, 2% SDS, 100 mM β-mercaptoethanol, and 
dH2O) for 30 min at 50°C, and finally washing the blot with 1X PBS twice for 10 min 
each at room temperature. The blot was blocked again with 5% milk for at least 1 hr after 
stripping.  
 
6.12. Yeast two-hybrid 
Protein interactions were mapped using the yeast two-hybrid system with the DNA 
binding plasmid pDEST-GBKT7-BD-AttR1_2 and the activation domain plasmid pDEST-
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GADT7-AD-AttR1_2 [kindly provided by Michael White, University of Southern Florida 
(Invitrogen)] in the AH109 yeast-two hybrid reporter strain (Invitrogen). Genes were 
cloned into the plasmids by Gateway recombination cloning. Primer sequences are 
provided in Table 4.1 (148). A matrix of plasmid combinations were co-transformed into 
the AH109 strain using a modified version of the TRAFO high efficiency transformation 
protocol (149) and plated on -Leu/-Trp media (dropout powders and SD minimal agar 
media from Clontech).  Plates were grown at 30°C for four days and then replica plated 
to plates lacking histidine, adenine, leucine, and tryptophan (quadruple drop-out or QDO) 
and grown under the same conditions. The strengths of self-interactions were assessed by 
replica plating from QDO to 5 mM, 10 mM, 25 mM, and 50 mM 3-aminotriazole (3-AT). 
The empty pGBK and pGAD plasmids were used for negative controls and Snf4 and Snf1 
encoding plasmids pSE1112 and pSE1111, respectively, were used as positive controls 
(150). 
 
6.13. Plaque assays 
Confluent T-12.5 flasks of hTERT HFF cells were infected with 200 parasites in ED-1 or 
ED-1 with 1µg/mL ATc (Invitrogen) and incubated undisturbed at 37°C for 7 days. The 
monolayers were stained with crystal violet and the plaques counted. Total plaque area 
was quantified in Improvision Openlab (version 5.5.0) and average plaque size calculated 
by dividing total plaque area by the number of plaques.  
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Table 6.1. Primer Sequences 
 
Overview of all primer names and sequences used to generate plasmids for this study. 
Restriction enzyme sites are underlined. LIC extensions are in italics and bold font. AttB 
Gateway recombination sites are in bold font. 
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Table 5.1. Primer Sequences 
_______________________________________________________________________ 
Primer name   sequence 
_______________________________________________________________________ 
RACE primers 
_______________________________________________________________________ 
RACE-IMC7-5’    GGCGTTGAACTGGTTGAGCGCCTCGAGG  
RACE-IMC7-5’nest   CGCCGTTCGTCGTGCCGCAGTACCAAG 
RACE-IMC7-3’    CGGAAATCGCGCGCTTTGTACCCTCCGTC  
RACE-IMC9-5’           CGGACTTCAACAATCTTGTCGACAGGAACG 
RACE-IMC9-5’nest      CGAATTTCTCAGCGACGACGCACTGCG 
RACE-IMC9-3’           GCCTCAGGTGATGGTTCGAGAACGCG 
RACE-IMC9-3’nest       CGTCCGAAAGGAGAAGGTCGTCACAATTC 
RACE-IMC12-5’   CCTCGACGTATCGGGGCACATAAATCGGC 
RACE-IMC12-5’nest  GACGTCGTAGTACTTGGGCTGAATCCGGG 
RACE-IMC12-3’   GCCAGTCGAAGTCACCAAGGTTGCTGTG 
RACE-IMC12-3’nest  GCCGCGTGAAGTCAACGTCATCCAGGC 
RACE-IMC13-5’    GCTTTTCAATGATGCGTTCCTGAGGGACG 
RACE-IMC13-5’nest  CGGACCGGGAACATGGCGAATCTTCTCG 
RACE-IMC13-3’    GTGCCACGAACTGACATTCAGTGGGTGG 
RACE-IMC13-3’nest  GGAGAAGTACGTGGAGGTTCCACAGATC  
RACE-IMC14-3’    ATGGAGCTCTGCGAGAGCCCCTGCTGCG 
RACE-IMC14-3’nest  CGGTACTCCCACTCGCCACCGTTGGAG 
RACE-IMC15-5’  GTGAATTTGTCGTGCACGACCACATATGGC 
RACE-IMC15-5’nest  CGGTATGTGGTTAATGACAGTGTCGCGGAG 
RACE-IMC15-3’  CACATGGTCCCGCGGTTACGCCCAGTG 
RACE-IMC15-3’nest  GAGGTCGAGAAGTTTGTCGAGGTTCCAG 
_______________________________________________________________________ 
YFP/RFP fusion primers 
______________________________________________________________________ 
3dhfr-Not-R   GGTGGCGGCCGCTCTAGAAC 
YFPIMC3-F          cagCCTAGGATGTCGGACGCCGGGACCCCG  
YFPIMC3-R    cagGATATCtcaCTGCTCGTAGACGACTTCGCGCTC 
IMC3-BamHI-F   cagGGATCCATGTCGGACGCCGGGACCCCG 
IMC3-AvrII-R   cagCCTAGGCTGCTCGTAGACGACTTCGCGCTC 
IMC4-F-AvrII   cagCCTAGGatgttttctgagtgctgccagc  
IMC4-R-RV    cagGATATCctagttgatattgacttgggtctg 
IMC4-F-Bgl   cagAGATCTaaaATGTTTTCTGAGTGCTGCCAG 
IMC4-R-Avr   cagCCTAGGGTTGATATTGACTTGGGTC 
IMC5-F-AvrII   CCTAGGatggttcagttcgcgcacggcc  
IMC5-R-XmaI        CCCGGGctattcccctccatttcgacagtc 
IMC6anno-F-Avr  cagCCTAGGATGGCTCAGACAGCCCCGAAC  
IMC6anno-R-RV  cagGATATCTCAGTGCACCTCGCCTTCGGAG  
IMC6-F-Bgl   cagAGATCTaaaATGGCTCAGACAGCCCCGAAC 
IMC6-R-Avr   cagCCTAGGGTGCACCTCGCCTTCGGAG 
IMC7-F-Avr   cagCCTAGGATGGAGTTCACTGCTGACAAC 
IMC7-R-RV   cagGATATCCTACGCAGCGATTGGGAC 
IMC7-F-Bgl   cagAGATCTATGGAGTTCACTGCTGACAAC 
IMC7-R-Avr   cagCCTAGGCGCAGCGATTGGGACAGCGGTG 
pIMC7-F-PmeI    cagGTTTAAACGTGGGCTCGTCTGGTTTTCTCCG 
pIMC7-R-BglII     cagAGATCTTGCGAAGAAGGCGTGAAAAAGCAAG  
IMC8anno-F-Avr  cagCCTAGGATGTATTCCAGCAGACCGTATCCTG  
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IMC8twin-F-Avr  cagCCTAGGATGTCGTCGCAGTATGCTACCTC  
IMC8-R-RV   cagGATATCTTACATCGGAGTCGGTGGAAAGGGC 
IMC9-F-TgG-AvrII   cagCCTAGGATGGCTTCGTCCTCAGCCCCG 
IMC9-R-RV          cagGATATCCTAGTTGACGGCCTGTGAGAG 
IMC10-F-AvrII   cagCCTAGGATGTCTCAGTTTCAACAGCCAC 
IMC10-R-RV    cagGATATCTTAGGCGCTGATCTGTGCCTC 
IMC10-F-Bgl   cagAGATCTaaaATGTCTCAGTTTCAACAGCC 
IMC10-R-Avr   cagCCTAGGGGCGCTGATCTGTGCCTCTTC 
IMC11-F-Avr   cagCCTAGGATGAGCGGCTGCCAGCAAAACGAC  
IMC11anno-R-NruI  cagTCGCGATCACCTGACGCGGTATTGGTCATC  
IMC11-F-Bgl   cagAGATCTaaaATGAGCGGCTGCCAGCAAAAC 
IMC11(TwSc)-R-Avr  cagCCTAGGCCTGACGCGGTATTGGTC 
pimc11-F-Pme  cagGTTTAAACGAGTGGGAGACGGCAAGCTTG 
IMC11(ME49)-R-Nhe  cagGCTAGCACCCTCTAACCAGGCACAGGC 
IMC11-F-XmaI       cagCCCGGGATGAGCGGCTGCCAGCAAAACGAC 
YFPIMC12-F         cagCCTAGGATGGCAACCGAGTTCGTCGTTC  
YFPIMC12-R    cagGATATCtcaCTGGGGCATGGAGTCGACG 
IMC12-F-Bgl           cagAGATCTATGGCAACCGAGTTCGTCGTTC  
IMC12-R-Avr           cagCCTAGGCTGGGGCATGGAGTCGACGGAC 
pIMC12-F-PmeI    cagGTTTAAACCACCAACAAATCCAACAACTTCCG  
pIMC12-R-BglII    cagAGATCTCTGCAAATTCACAGAGCGAAGTAGC  
IMC12-F-NruI   cagTCGCGAATGGCAACCGAGTTCGTCGTTC 
IMC13-F-Avr   cagCCTAGGATGGAAACGATGGCTCAGCAG 
IMC13-R-RV   cagGATATCTTACTTCTCGAAGCCAGGCG 
IMC13-F-Bgl           cagAGATCTATGGAAACGATGGCTCAGCAG 
IMC13-R-Avr           cagCCTAGGCTTCTCGAAGCCAGGCGAAGAG 
IMC14-F-Nhe   cagGCTAGCATGGAGCTCTGCGAGAGCCCCTG 
IMC14-R-RV   cagGATATCTCACCTTTTCATAAAGTCTTCGTTG 
IMC14-F-Bgl         cagAGATCTATGGAGCTCTGCGAGAGCCCCTG 
IMC14-R-Nhe          cagGCTAGCCCTTTTCATAAAGTCTTCGTTGTTCAG 
pIMC14-F-PmeI    cagGTTTAAACTCGCATGCTGAGGAACCAACC  
pIMC14-R-BglII    cagAGATCTCGTGTCCACTATTGGTAACGGAT  
IMC15-F-NheI   cagGCTAGCATGCGGATCTGCTTGCCACCAG  
IMC15-R-XmaI   cagCCCGGGTCAGTTCGGATAAGACAACGTGTTG 
IMC15-F-Bgl   cagagatctaaaatgcggatctgct 
IMC15-R-Nhe   caggctagcgttcggataagacaacgtg 
pIMC15-F-PmeI    cagGTTTAAACCGCCAATAACAGCACTGACCACAG 
pIMC15-R-BglII    cagAGATCTTTTAGAAAAATTCTCTCCTATGCTGCTG 
TgCAM1-BglII-F  ccgAGATCTATGCCGCCTCGGGGCAG 
TgCAM1-AvrII-R  ggcCCTAGGTTTATTCGCGGAAGGC 
_____________________________________________________________________ 
DD system primers 
_____________________________________________________________________ 
Nhe-Sph-YFP-F   cagGCTAGCaGCATGCcagtgagcaagggcgaggagctg 
3dhfr-Not-R   GGTGGCGGCCGCTCTAGAAC 
__________________________________________________________ 
Recombinant protein expression / LIC primers 
_____________________________________________________________________ 
IMC5-LIC-F   gggtcctggttcgATGGTTCAGTTCGCGCACGCC 
IMC5-LIC-R   cttgttcgtgctgtttaCTACGGGCC TTGCGGCGGTAAC 
IMC11-F-LIC   gggtcctggttcgATGAGCGGCTGCCAGCAAAACGAC  
IMC11-R-LIC   cttgttcgtgctgtttaTTACCTGACGCGGTATTGGTCATC  
IMC15-LIC-F   gggtcctggttcgATGCGGATCTGCTTGCCACC 
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IMC15-LIC-R   cttgttcgtgctgtttaCTAGACTACTTTGACTACAGG 
_____________________________________________________________________ 
Deletion and Chimera construct primers 
_____________________________________________________________________ 
IMC3-AR-RV   cagGATATCttaTGGCGGCTGGTACGGGATTTC 
IMC3-AF-Avr   cagCCTAGGCCTCCAGAGGTCCGACAGAAG 
IMC8-AR-RV   cagGATATCttaATCCTCGTCCACGTAGACGAC 
IMC8-AF-Avr   cagCCTAGGGACCCTGTACTCGAGGAACGG 
IMC8-CF-3AR   GAAATCCCGTACCAGCCGCCAGGTAGCCAAACGCGCGTTCCG 
IMC3-NR-8AF   CCGTTCCTCGAGTACAGGGTCCAGCGGCATCGGGCCGAG 
IMC3-CF-8AR   GTCGTCTACGTGGACGAGGATGACGCGGCGACCCTCCCGCCC 
IMC8-NR-3AF   CTTCTGTCGGACCTCTGGAGGAAGAAGGGTTGCACCTTCGGG 
IMC3-CF-Avr     cagCCTAGGGACGCGGCGACCCTCCCGCCCTTG 
IMC15-CF   caggctagcagtgttcacaaaacaaaaagcaaagtttc 
IMC15-NRnew   cagCCCGGGtcaTGCCTGAGTGGTCTTCGCTCTG  
IMC15-ARnew   cagCCCGGGtcaCCGTTCTTTATCTAGGTGAGTGAC  
IMC15-AFnew   cagGCTAGCGTTGTTGAACAGAAGATGGTCCCG 
IMC15-CFnew   cagGCTAGCCTAACAGCCGAGCAACAGGAAC  
IMC15-CF-NRnew  CAGAGCGAAGACCACTCAGGCACTAACAGCCGAGCAACAGGAAC 
 
___________________________________________________________________ 
Yeast two hybrid primers 
___________________________________________________________________ 
Att-B1-adapt  GGGGACAAGTTTGTACAAAAAAGCAGGCT 
Att-B2-adapt  GGGGACCACTTTGTACAAGAAAGCTG 
AttB1-F-IMC3   AAAAAGCAGGCTccATGTCGGACGCCGGGACC 
AttB2-R-IMC3   AGAAAGCTGGGTgtcaCTGCTCGTAGACGACTTCG  
AttB1-F-IMC5   AAAAAGCAGGCTccatggttcagttcgcgcacggcc 
AttB2-R-IMC5       AGAAAGCTGGGTgctattcccctccatttcgacagtc 
AttB1-F-IMC8   AAAAAGCAGGCTccATGTATTCCAGCAGACCGTATC  
AttB2-R-IMC8   AGAAAGCTGGGTgTTACATCGGAGTCGGTGGAAAG 
AttB1-F-IMC9.GL  AAAAAGCAGGCTccATGGCTTCGTCCTCAGCCCCG 
AttB2-R-IMC9.GL  AGAAAGCTGGGTgCTAGTTGACGGCCTGTGAGAG 
AttB1-F-IMC13   AAAAAGCAGGCTccATGGAAACGATGGCTCAGCAG 
AttB2-R-IMC13   AGAAAGCTGGGTgTTACTTCTCGAAGCCAGGCG 
AttB1-F-IMC15   AAAAAGCAGGCTccATGCGGATCTGCTTGCCACCAG                     
AttB2-R-IMC15   AGAAAGCTGGGTgTCAGTTCGGATAAGACAACGTGTTG 
AttB1-F-Centrin2   AAAAAGCAGGCTcccagcgaggagcactgcg  
AttB2-R-Centrin2   AGAAAGCTGGGTgtcacgggaaagtcttcttggtc 
AttB1-F-MORN1  AAAAAGCAGGCTAATGGAGAGCTGCCACGCG 
AttB2-R-MORN1  AGAAAGCTGGGTGCAAGTCGACATTGAGCCATG 
AttB2-R-MORN1.1-6  AGAAAGCTGGGTGTCAACCTTTGGCACTGA 
AttB1-F-MORN1.13-AG  AAAAAGCAGGCTccTACGAAGGCGAATGGACAGAC  
AttB2-R-MORN1.13-AG  AGAAAGCTGGGTgtcaCAAGTCGACATTGAGCCATGG 
___________________________________________________________________ 
Endogenous tagging and KO primers 
___________________________________________________________________ 
IMC15-F-Ku80LIC   TACTTCCAATCCAATTTAATGGCCCGCTCTAGGTTACATAGTC 
IMC15-R-Ku80LIC   TCCTCCACTTCCAATTTTAGCGTTCGGATAAGACAACGTGTTG 
5’IMC15-F-B1  GGGGACAAGTTTGTACAAAAAAGCAGGCTgcCGGTGGGCTGTTCTAAAGAAAGAC 
5’IMC15-R-B4  GGGGACAACTTTGTATAGAAAAGTTGGGTGCTAACGGCAACACGAAACTGGC  
3’IMC15-F-B3  GGGGACAACTTTGTATAATAAAGTTGcgCTCCTCCTTGAGGAGACGGATTG  
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3’IMC15-R-B2  GGGGACCACTTTGTACAAGAAAGCTGGGTACTGAGAGGACAAACTGGCCG  
5UPRT-F-XhoI  cagCTCGAGGGAATCTACACACCGGAAGGTTC  
5UPRT-R-BglII  cagAGATCTGTTTAAACACCGGTCAGCGGAGGCTCAGCGTTTCCTG 
3UPRT-F-AvrII  cagCCTAGGGCGGCCGCGTTAACGTGAGGCTGCCTGGTGCGCGACAAG  
3UPRT-R-BamHI  cagGGATCCGGAATCAGACCCTCGTCTCCGGTGG 
5’IMC15-F-AseI    cagATTAATCGGTGGGCTGTTCTAAAGAAAGAC 
5’IMC15-R-AseI    cagATTAATCTAACGGCAACACGAAACTGGC 
IMC15int-R-NheI   caggctagcATTTTCGACGACGCTCACTGGGC 
___________________________________________________________________ 
KO verification primers 
___________________________________________________________________ 
myc-F1   gatctaaaatggaacaaaagctaatctccgaggaagacttgaacg 
5’IMC15ver-F  GTGTACTGGTGTTCGAGGCTATG 
3’IMC15ver-R  CAAACCAAATGATGCGGTCCCTG 
HX-ver-F   gccgctcgcaaaaagttcgagaag 
HX-ver-R   gtagtcttcaatgggtttggacgc 
IMC15int-ver-R  GATGTAGGCACGACTTCGGCG 
5’UPRT-F-ver  CGGTGTGGTTCCTGTTGACTTAG 
3’UPRT-R-ver  GTGCAGGGAGGTTTGTTATCTTG 
UPRT-F-ver   CGTTTCTTACTGGCATCGAATG   
UPRT-R-ver   GTTGTTTCGTCTCTCTGGATG 
5’DHFRCXR   ACTGCGAACAGCAGCAAGATCG 
T7Sag4-F-PmeI  caggtttaaaccactagttctagaaggaccCGGTAC 
IMC15int-ver-R(alveolin)GACTACAGGAATCTCGATGCG 
pimc15-ver-F  CGTCACAGCAGCATAGGAGAG 
Tet7ver-F         GAGGTCGACGGTATCGATAAGC   
_____________________________________________________________________ 
Mutagenesis primers (mutation is lowercase) 
_____________________________________________________________________ 
IMC15.C4A-F-NheI        cagGCTAGCATGCGGATCgcgTTGCCACCAGTGCCTCAG   
IMC15.C92/3A-F    CGCAGAATCCGCAGCAGCTgcggcgCTTTGGCAAACAAGCCCACG                   
IMC15.C92/3A-R          CGTGGGCTTGTTTGCCAAAGcgccgcAGCTGCTGCGGATTCTGCG 
IMC15.C673/4A-F         GCCCAGTTCTGTTGATGCACAGgcggcgCAGTCACCGTGGACACAACATG  
IMC15.C673/4A-R         CATGTTGTGTCCACGGTGACTGcgccgcCTGTGCATCAACAGAACTGGGC          
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